// User Generated Content (UGC) Management

// UGC Data Management System
class UGCManager {
    constructor() {
        this.storageKey = 'llab-ugc-content';
        this.init();
    }
    
    init() {
        // Initialize with sample data if no data exists
        if (!localStorage.getItem(this.storageKey)) {
            this.initSampleData();
        }
    }
    
    initSampleData() {
        const sampleData = {
            Research: [
                {
                    id: 'research_001',
                    title: 'Novel AI-Driven Biomarker Discovery in Cancer Genomics',
                    type: 'research-paper',
                    author: 'Dr. Sarah Chen',
                    authorEmail: 'sarah.chen@llab.com',
                    date: '2025-06-15',
                    content: `# Novel AI-Driven Biomarker Discovery in Cancer Genomics

## Abstract
We present a comprehensive machine learning framework for identifying novel biomarkers in cancer genomics using multi-omics data integration. Our approach combines deep learning with traditional statistical methods to achieve unprecedented accuracy in biomarker identification.

## Introduction
Cancer biomarker discovery remains one of the most challenging aspects of precision medicine. Traditional approaches often fail to capture the complex interactions between genomic, transcriptomic, and proteomic data.

## Methods
### Data Collection
- **Genomic Data**: Whole genome sequencing from 5,000 cancer patients
- **Transcriptomic Data**: RNA-seq profiles across 12 cancer types
- **Proteomic Data**: Mass spectrometry data from tissue samples
- **Clinical Data**: Treatment outcomes and survival data

### AI Framework
Our framework consists of three main components:
1. **Multi-modal Autoencoder**: For feature extraction and dimensionality reduction
2. **Graph Neural Network**: For capturing molecular interactions
3. **Ensemble Classifier**: For final biomarker prediction

## Results
- **Sensitivity**: 94.2% (95% CI: 92.1-96.3)
- **Specificity**: 91.8% (95% CI: 89.5-94.1)
- **Novel Biomarkers Identified**: 127 previously unknown biomarkers
- **Validation**: Independent cohort validation with 89.3% accuracy

## Clinical Implications
The identified biomarkers show strong potential for:
- Early cancer detection
- Treatment selection
- Prognosis prediction
- Drug response monitoring

## Conclusion
Our AI-driven approach represents a significant advancement in cancer biomarker discovery, with immediate clinical applications and potential for improving patient outcomes.`,
                    excerpt: 'A groundbreaking machine learning framework that identifies novel cancer biomarkers through multi-omics data integration, achieving 94.2% sensitivity in clinical validation.',
                    tags: ['AI', 'biomarkers', 'cancer genomics', 'machine learning', 'precision medicine'],
                    likes: 89,
                    views: 1247,
                    downloads: 156,
                    shares: 43,
                    status: 'approved',
                    files: [
                        { name: 'biomarker_ai_framework.pdf', size: '2.8 MB', type: 'application/pdf' },
                        { name: 'supplementary_data.xlsx', size: '15.2 MB', type: 'application/excel' },
                        { name: 'analysis_code.zip', size: '8.7 MB', type: 'application/zip' }
                    ]
                },
                {
                    id: 'research_002',
                    title: 'Federated Learning for Privacy-Preserving Medical AI',
                    type: 'research-paper',
                    author: 'Prof. Michael Rodriguez',
                    authorEmail: 'michael.r@llab.com',
                    date: '2025-06-12',
                    content: `# Federated Learning for Privacy-Preserving Medical AI

## Abstract
We propose a federated learning framework that enables collaborative training of medical AI models while preserving patient privacy and complying with healthcare regulations.

## Background
Medical AI development faces significant challenges:
- **Data Privacy**: HIPAA and GDPR compliance requirements
- **Data Silos**: Hospitals reluctant to share sensitive data
- **Model Generalization**: Need for diverse training data
- **Regulatory Compliance**: Strict healthcare data regulations

## Our Approach
### Federated Architecture
- **Local Training**: Models trained on local hospital data
- **Secure Aggregation**: Encrypted model parameter sharing
- **Differential Privacy**: Mathematical privacy guarantees
- **Audit Trail**: Complete training process documentation

### Technical Implementation
- **Framework**: Custom PyTorch federated learning library
- **Security**: Homomorphic encryption for parameter aggregation
- **Communication**: Optimized sparse gradient sharing
- **Scalability**: Support for 100+ participating institutions

## Validation Studies
### COVID-19 Diagnosis
- **Participants**: 15 hospitals across 3 countries
- **Data**: 50,000 chest X-rays
- **Performance**: 96.1% accuracy (vs 89.3% single-hospital models)
- **Privacy**: Zero patient data exposure verified

### Cancer Classification
- **Participants**: 8 cancer centers
- **Data**: Histopathology images from 5 cancer types
- **Performance**: 93.7% classification accuracy
- **Improvement**: 12% better than isolated models

## Impact and Adoption
- **Clinical Deployment**: 3 hospitals using federated models in production
- **Regulatory Approval**: FDA breakthrough device designation
- **International Collaboration**: 25 institutions in federated network
- **Open Source**: Framework released under Apache 2.0 license

## Future Directions
- **Real-time Federated Learning**: Continuous model updates
- **Multi-modal Integration**: Combining imaging, genomics, and clinical data
- **Blockchain Integration**: Immutable audit trails
- **Edge Computing**: Federated learning on medical devices`,
                    excerpt: 'Revolutionary federated learning framework enabling collaborative medical AI development while maintaining strict patient privacy and regulatory compliance.',
                    tags: ['federated learning', 'medical AI', 'privacy', 'healthcare', 'collaboration'],
                    likes: 134,
                    views: 2156,
                    downloads: 287,
                    shares: 78,
                    status: 'approved',
                    files: [
                        { name: 'federated_learning_paper.pdf', size: '4.2 MB', type: 'application/pdf' },
                        { name: 'framework_implementation.py', size: '45.6 KB', type: 'text/python' },
                        { name: 'demo_deployment.zip', size: '12.3 MB', type: 'application/zip' }
                    ]
                },
                {
                    id: 'research_003',
                    title: 'Explainable AI for Clinical Decision Support in Oncology',
                    type: 'research-paper',
                    author: 'Dr. Elena Vasquez',
                    authorEmail: 'elena.v@llab.com',
                    date: '2025-06-10',
                    content: `# Explainable AI for Clinical Decision Support in Oncology

## Abstract
We present an explainable artificial intelligence (XAI) framework designed to assist oncologists in making evidence-based treatment decisions while providing transparent, interpretable explanations for AI recommendations.

## Introduction
### Clinical Challenge
Modern oncology generates vast amounts of multi-modal data:
- **Genomic Profiles**: Tumor sequencing data
- **Imaging Studies**: CT, MRI, PET scans
- **Clinical Records**: Patient history, lab results
- **Literature Evidence**: Latest research findings
- **Treatment Outcomes**: Response data from similar cases

### The Black Box Problem
Traditional AI models in healthcare often operate as "black boxes":
- **Lack of Transparency**: No insight into decision-making process
- **Regulatory Concerns**: FDA requires explainable medical AI
- **Clinician Trust**: Doctors need to understand AI reasoning
- **Patient Safety**: Unexplained decisions pose risks
- **Legal Liability**: Need for auditable decision trails

## Methodology
### XAI Architecture
Our framework consists of four integrated components:

#### 1. Multi-Modal Data Integration
- **Genomic Analysis Module**: Processes tumor sequencing data
- **Imaging Analysis Module**: Extracts features from medical images
- **Clinical Data Module**: Structures patient history and lab results
- **Literature Mining Module**: Incorporates latest research evidence

#### 2. Ensemble Prediction Engine
- **Random Forest**: For baseline predictions with feature importance
- **Deep Neural Networks**: For complex pattern recognition
- **Gradient Boosting**: For handling imbalanced datasets
- **SVM with SHAP**: For interpretable classification boundaries

#### 3. Explanation Generation
- **SHAP Values**: Quantifies feature contributions to predictions
- **LIME**: Local explanations for individual predictions
- **Attention Mechanisms**: Highlights important regions in images
- **Counterfactual Explanations**: Shows what would change predictions

#### 4. Clinical Interface
- **Interactive Dashboard**: Real-time visualization of AI reasoning
- **Confidence Intervals**: Uncertainty quantification for predictions
- **Similar Cases**: Shows comparable patients and outcomes
- **Evidence Links**: Direct connections to supporting literature

## Validation and Results
### Clinical Trial Design
- **Setting**: Multi-center trial across 8 cancer centers
- **Participants**: 45 oncologists, 1,200 cancer patients
- **Duration**: 18-month prospective study
- **Endpoints**: Decision accuracy, clinician trust, patient outcomes

### Performance Metrics
#### Prediction Accuracy
- **Treatment Response**: 87.3% accuracy (vs 78.9% standard care)
- **Progression-Free Survival**: 91.2% 6-month prediction accuracy
- **Toxicity Prediction**: 94.5% sensitivity, 89.7% specificity
- **Biomarker Discovery**: 23 novel predictive markers identified

#### Clinician Adoption
- **Trust Score**: 8.7/10 average clinician trust rating
- **Usage Rate**: 94% of participating oncologists used system regularly
- **Decision Time**: 34% reduction in time to treatment decision
- **Confidence**: 42% increase in clinician decision confidence

#### Patient Outcomes
- **Overall Survival**: 15% improvement in 2-year survival rates
- **Quality of Life**: Significant improvement in patient-reported outcomes
- **Treatment Adherence**: 28% increase in treatment completion rates
- **Adverse Events**: 22% reduction in severe adverse events

### Explanation Quality Assessment
#### Quantitative Metrics
- **Fidelity**: 96.3% agreement between explanations and model behavior
- **Consistency**: 92.1% consistency across similar cases
- **Comprehensiveness**: 89.4% of decision factors adequately explained
- **Actionability**: 85.7% of explanations led to actionable insights

#### Qualitative Feedback
- **Clarity**: Explanations rated as clear and understandable
- **Relevance**: High clinical relevance of highlighted features
- **Completeness**: Comprehensive coverage of decision factors
- **Trustworthiness**: Increased confidence in AI recommendations

## Clinical Impact and Deployment
### Implementation Strategy
#### Phase 1: Pilot Deployment
- **Single Institution**: Initial deployment at major cancer center
- **Limited Scope**: Focus on breast and lung cancer cases
- **User Training**: Comprehensive clinician education program
- **Iterative Improvement**: Weekly feedback sessions and updates

#### Phase 2: Multi-Center Rollout
- **Expanded Network**: 8 cancer centers across 4 countries
- **Broader Scope**: All major cancer types included
- **Integration**: Full EHR integration with clinical workflows
- **Quality Assurance**: Continuous monitoring and validation

#### Phase 3: Production Deployment
- **Wide Adoption**: 50+ institutions using the system
- **Real-World Evidence**: Ongoing outcomes monitoring
- **Regulatory Approval**: FDA clearance for clinical decision support
- **Commercial Availability**: Licensed to healthcare technology companies

### Real-World Performance
#### Clinical Outcomes
- **Decision Accuracy**: Sustained 12% improvement over standard care
- **Diagnostic Speed**: 40% faster time to definitive diagnosis
- **Treatment Optimization**: 18% increase in treatment response rates
- **Cost Effectiveness**: $15,000 average savings per patient

#### Workflow Integration
- **EHR Compatibility**: Seamless integration with major EHR systems
- **Alert Fatigue**: Minimal increase in alert burden (2.3 alerts/day)
- **User Satisfaction**: 91% clinician satisfaction with system
- **Patient Acceptance**: 88% patient approval of AI-assisted care

## Technical Innovation
### Novel Contributions
#### 1. Multi-Scale Attention Mechanism
- **Genomic Level**: Identifies key mutations and pathways
- **Cellular Level**: Highlights important histological features
- **Tissue Level**: Focuses on relevant anatomical regions
- **Patient Level**: Considers demographic and clinical factors

#### 2. Temporal Explanation Framework
- **Disease Progression**: Explains how AI predicts disease evolution
- **Treatment Timeline**: Shows optimal timing for interventions
- **Outcome Trajectories**: Visualizes potential future scenarios
- **Dynamic Updates**: Explanations evolve with new data

#### 3. Uncertainty-Aware Explanations
- **Confidence Bounds**: Quantifies uncertainty in explanations
- **Sensitivity Analysis**: Shows robustness to input variations
- **Alternative Scenarios**: Presents multiple plausible explanations
- **Risk Assessment**: Explicit uncertainty communication

### Software Architecture
#### Backend Infrastructure
- **Microservices**: Scalable, modular architecture
- **API Gateway**: Standardized access to AI services
- **Message Queue**: Asynchronous processing of complex analyses
- **Database**: Distributed storage for multi-modal data

#### Frontend Interface
- **Responsive Design**: Works on desktops, tablets, and mobile devices
- **Interactive Visualizations**: D3.js-based explanation graphics
- **Real-time Updates**: WebSocket connections for live data
- **Accessibility**: WCAG 2.1 compliant for all users

## Regulatory and Ethical Considerations
### FDA Compliance
- **510(k) Clearance**: Approved as Class II medical device
- **Clinical Evidence**: Extensive validation studies submitted
- **Post-Market Surveillance**: Ongoing safety and effectiveness monitoring
- **Quality Management**: ISO 13485 certified manufacturing process

### Privacy and Security
- **HIPAA Compliance**: Full adherence to healthcare privacy regulations
- **Data Encryption**: End-to-end encryption for all patient data
- **Access Controls**: Role-based permissions and audit logs
- **Anonymization**: De-identification of data for research use

### Ethical AI Principles
- **Fairness**: Tested for bias across demographic groups
- **Transparency**: Open explanation methodology
- **Accountability**: Clear responsibility chains for AI decisions
- **Human Oversight**: Always maintains clinician in decision loop

## Future Directions
### Technical Enhancements
#### Advanced Explanation Methods
- **Causal Reasoning**: Moving beyond correlation to causation
- **Analogical Explanations**: Using similar case comparisons
- **Natural Language**: Automated generation of text explanations
- **Interactive Exploration**: Allowing clinicians to probe AI reasoning

#### Multi-Modal Integration
- **Genomic-Imaging Fusion**: Combined analysis of molecular and imaging data
- **Time-Series Analysis**: Incorporating longitudinal patient data
- **Social Determinants**: Including socioeconomic factors in models
- **Real-World Evidence**: Integration of outcomes data from multiple sources

### Clinical Expansion
#### New Cancer Types
- **Rare Cancers**: Extending to uncommon malignancies
- **Pediatric Oncology**: Specialized models for childhood cancers
- **Hematologic Malignancies**: Blood cancers and leukemias
- **Metastatic Disease**: Focus on advanced-stage cancers

#### Treatment Modalities
- **Immunotherapy**: Specialized models for immune checkpoint inhibitors
- **CAR-T Therapy**: Decision support for cellular therapies
- **Radiation Therapy**: Treatment planning and outcome prediction
- **Surgical Planning**: Pre-operative risk assessment and optimization

### Global Health Impact
#### International Deployment
- **Low-Resource Settings**: Adaptation for developing countries
- **Telemedicine Integration**: Remote consultation support
- **Language Localization**: Support for multiple languages
- **Cultural Adaptation**: Consideration of regional medical practices

#### Education and Training
- **Medical Education**: Integration into oncology training programs
- **Continuing Education**: Ongoing learning modules for practicing clinicians
- **Patient Education**: Tools for explaining AI-assisted decisions to patients
- **Public Awareness**: Promoting understanding of AI in healthcare

## Conclusion
Our explainable AI framework represents a significant advancement in clinical decision support for oncology. By providing transparent, interpretable AI recommendations, we enable clinicians to make more informed decisions while maintaining trust and accountability in AI-assisted healthcare. The successful deployment across multiple institutions demonstrates the practical value and clinical impact of explainable AI in real-world oncology practice.

The combination of high prediction accuracy with clear, actionable explanations addresses the critical gap between AI capability and clinical adoption. As we continue to refine and expand the system, we anticipate even greater impact on cancer care quality and patient outcomes.

## Acknowledgments
We thank the participating oncologists, patients, and institutions who made this research possible. Special recognition goes to the clinical advisory board who provided invaluable guidance throughout the development and validation process.`,
                    excerpt: 'Comprehensive explainable AI framework for oncology clinical decision support, achieving 87.3% treatment response prediction accuracy with transparent, interpretable explanations trusted by clinicians.',
                    tags: ['explainable AI', 'oncology', 'clinical decision support', 'XAI', 'cancer treatment', 'medical AI'],
                    likes: 198,
                    views: 3421,
                    downloads: 456,
                    shares: 112,
                    status: 'approved',
                    files: [
                        { name: 'xai_oncology_framework.pdf', size: '6.8 MB', type: 'application/pdf' },
                        { name: 'clinical_validation_results.xlsx', size: '28.4 MB', type: 'application/excel' },
                        { name: 'explanation_algorithms.zip', size: '15.7 MB', type: 'application/zip' },
                        { name: 'user_interface_demo.mp4', size: '45.2 MB', type: 'video/mp4' }
                    ]
                }
            ],
            Methods: [
                {
                    id: 'methods_001',
                    title: 'Introduction to Deep Learning for Medical Image Analysis',
                    type: 'blog',
                    author: 'Dr. Alex Chen',
                    authorEmail: 'alex.chen@llab.com',
                    date: '2025-06-14',
                    content: `# Introduction to Deep Learning for Medical Image Analysis

## Overview
Deep learning has revolutionized medical image analysis, particularly in pathology and radiology. This blog post explores the fundamental concepts and practical applications.

## Key Concepts
- **Convolutional Neural Networks (CNNs)**: The backbone of medical image analysis
- **Transfer Learning**: Leveraging pre-trained models for medical applications
- **Data Augmentation**: Techniques to improve model robustness

## Getting Started
1. Choose appropriate architecture (ResNet, DenseNet, EfficientNet)
2. Prepare your dataset with proper annotations
3. Implement data preprocessing pipelines
4. Train with careful validation strategies

## Conclusion
Deep learning offers unprecedented opportunities in medical AI, but requires careful consideration of data quality, model interpretability, and clinical validation.`,
                    excerpt: 'A comprehensive guide to implementing convolutional neural networks for pathology image analysis, covering key concepts and practical implementation strategies.',
                    tags: ['deep learning', 'CNN', 'medical imaging', 'pathology'],
                    likes: 45,
                    views: 289,
                    downloads: 67,
                    shares: 23,
                    status: 'approved',
                    files: []
                },
                {
                    id: 'methods_002', 
                    title: 'Step-by-Step Tutorial: Building a Custom Annotation Tool',
                    type: 'tutorial',
                    author: 'Sarah Johnson',
                    authorEmail: 'sarah.j@llab.com',
                    date: '2025-06-12',
                    content: `# Building a Custom Annotation Tool

## Prerequisites
- Basic knowledge of HTML5 Canvas
- JavaScript ES6+
- Understanding of coordinate systems

## Step 1: Setting Up the Canvas
First, create the basic HTML structure:

\`\`\`html
<canvas id="annotationCanvas" width="800" height="600"></canvas>
\`\`\`

## Step 2: Initialize Drawing Context
\`\`\`javascript
const canvas = document.getElementById('annotationCanvas');
const ctx = canvas.getContext('2d');
\`\`\`

## Step 3: Implement Mouse Event Handlers
\`\`\`javascript
let drawing = false;
let annotations = [];

canvas.addEventListener('mousedown', startDrawing);
canvas.addEventListener('mousemove', draw);
canvas.addEventListener('mouseup', stopDrawing);
\`\`\`

## Step 4: Add Annotation Types
Implement different annotation types:
- Rectangle annotations
- Polygon annotations  
- Point annotations

## Step 5: Save and Load Annotations
Create functions to persist annotations:
\`\`\`javascript
function saveAnnotations() {
    localStorage.setItem('annotations', JSON.stringify(annotations));
}
\`\`\`

## Conclusion
You now have a basic annotation tool that can be extended with additional features like multi-user collaboration and cloud storage.`,
                    excerpt: 'Learn how to create a web-based annotation tool for histopathology images using JavaScript and Canvas API with step-by-step instructions.',
                    tags: ['tutorial', 'annotation', 'javascript', 'canvas'],
                    likes: 67,
                    views: 412,
                    downloads: 189,
                    shares: 34,
                    status: 'approved',
                    files: [
                        { name: 'annotation-tool-demo.html', size: '15.2 KB', type: 'text/html' },
                        { name: 'annotation-styles.css', size: '8.7 KB', type: 'text/css' }
                    ]
                },
                {
                    id: 'methods_003',
                    title: 'Research Protocol: Multi-Modal Data Integration',
                    type: 'documentation',
                    author: 'Prof. Michael Rodriguez',
                    authorEmail: 'michael.r@llab.com', 
                    date: '2025-06-10',
                    content: `# Multi-Modal Data Integration Protocol

## Overview
This document outlines the standardized protocol for integrating genomic, transcriptomic, and imaging data in cancer research studies.

## Data Requirements
- Genomic data: WGS or WES in VCF format
- Transcriptomic data: RNA-seq in FASTQ format
- Imaging data: WSI in SVS or TIFF format

## Integration Pipeline
1. **Data Quality Control**
   - Genomic QC using GATK best practices
   - RNA-seq QC with FastQC and MultiQC
   - Image quality assessment

2. **Data Preprocessing**
   - Variant calling and annotation
   - Gene expression quantification
   - Image preprocessing and tile extraction

3. **Feature Extraction**
   - Molecular features from omics data
   - Morphological features from images
   - Clinical variable encoding

4. **Data Integration**
   - Feature alignment and normalization
   - Multi-view learning approaches
   - Cross-modal validation

## Expected Outcomes
- Integrated dataset for downstream analysis
- Quality metrics and validation reports
- Reproducible analysis pipeline`,
                    excerpt: 'Detailed protocol for integrating genomic, transcriptomic, and imaging data in cancer research with quality control measures.',
                    tags: ['protocol', 'multi-modal', 'integration', 'genomics'],
                    likes: 34,
                    views: 156,
                    downloads: 89,
                    shares: 18,
                    status: 'approved',
                    files: [
                        { name: 'integration-protocol.pdf', size: '2.3 MB', type: 'application/pdf' },
                        { name: 'analysis-pipeline.py', size: '45.6 KB', type: 'text/python' },
                        { name: 'config-template.yaml', size: '3.1 KB', type: 'text/yaml' }
                    ]
                }
            ],
            Data: [
                {
                    id: 'data_001',
                    title: 'Comprehensive Multi-Omics Cancer Dataset (CMCD-2025)',
                    type: 'dataset',
                    author: 'L-Lab Data Consortium',
                    authorEmail: 'data@llab.com',
                    date: '2025-06-14',
                    content: `# Comprehensive Multi-Omics Cancer Dataset (CMCD-2025)

## Dataset Overview
The CMCD-2025 is the largest publicly available multi-omics cancer dataset, comprising genomic, transcriptomic, proteomic, and clinical data from 10,000 cancer patients across 15 cancer types.

## Data Composition
### Genomic Data
- **Whole Genome Sequencing**: Complete genome sequences for all samples
- **Exome Sequencing**: Targeted sequencing of protein-coding regions
- **Copy Number Variations**: Genome-wide CNV profiles
- **Structural Variants**: Large-scale genomic rearrangements

### Transcriptomic Data
- **RNA-seq**: Bulk RNA sequencing (>50M reads per sample)
- **Single-cell RNA-seq**: 500,000+ individual cell profiles
- **Long-read RNA-seq**: Full-length transcript characterization
- **miRNA-seq**: microRNA expression profiles

### Proteomic Data
- **Mass Spectrometry**: Quantitative proteomics (>8,000 proteins)
- **Immunohistochemistry**: Tissue protein localization
- **Flow Cytometry**: Immune cell profiling
- **Proximity Ligation Assays**: Protein-protein interactions

### Clinical Data
- **Demographics**: Age, gender, ethnicity, lifestyle factors
- **Treatment History**: Surgery, chemotherapy, radiation, immunotherapy
- **Outcomes**: Overall survival, progression-free survival, response rates
- **Biomarkers**: Traditional and novel biomarker measurements

## Quality Control
### Data Processing Pipeline
1. **Raw Data QC**: FastQC, MultiQC quality assessment
2. **Alignment**: BWA-MEM for DNA, STAR for RNA
3. **Variant Calling**: GATK best practices pipeline
4. **Expression Quantification**: RSEM, Salmon, Kallisto
5. **Normalization**: TMM, DESeq2, ComBat for batch correction

### Standards Compliance
- **FAIR Principles**: Findable, Accessible, Interoperable, Reusable
- **OMOP CDM**: Observational Medical Outcomes Partnership data model
- **HL7 FHIR**: Healthcare data exchange standards
- **ISO 27001**: Information security management

## Access and Usage
### Data Tiers
- **Tier 1 (Open)**: Summary statistics, metadata (no registration required)
- **Tier 2 (Controlled)**: De-identified clinical data (registration required)
- **Tier 3 (Restricted)**: Raw genomic data (institutional approval required)

### Download Options
- **API Access**: RESTful API with rate limiting
- **Bulk Download**: FTP/HTTPS for large datasets
- **Cloud Storage**: AWS S3, Google Cloud, Azure integration
- **Streaming**: Real-time data access for analysis

## Research Applications
### Completed Studies
- **Pan-cancer Analysis**: Cross-cancer type comparative genomics
- **Drug Discovery**: Target identification and validation
- **Biomarker Development**: Diagnostic and prognostic markers
- **Treatment Optimization**: Personalized therapy selection

### Ongoing Projects
- **AI Model Training**: Machine learning algorithm development
- **Multi-omics Integration**: Systems biology approaches
- **Clinical Trial Design**: Precision medicine trial optimization
- **Drug Resistance**: Mechanisms of therapeutic resistance

## Citation and Attribution
Please cite this dataset as:
L-Lab Data Consortium. (2025). Comprehensive Multi-Omics Cancer Dataset (CMCD-2025). Nature Scientific Data, 12, 123.

## Data Use Agreement
By accessing this dataset, users agree to:
- Use data solely for research purposes
- Acknowledge the data source in publications
- Share derived insights with the community
- Comply with applicable privacy regulations`,
                    excerpt: 'The largest multi-omics cancer dataset with genomic, transcriptomic, proteomic, and clinical data from 10,000 patients across 15 cancer types.',
                    tags: ['multi-omics', 'cancer genomics', 'dataset', 'FAIR data', 'precision medicine'],
                    likes: 267,
                    views: 3421,
                    downloads: 892,
                    shares: 156,
                    status: 'approved',
                    files: [
                        { name: 'dataset_documentation.pdf', size: '5.7 MB', type: 'application/pdf' },
                        { name: 'data_dictionary.xlsx', size: '2.1 MB', type: 'application/excel' },
                        { name: 'access_scripts.zip', size: '156 KB', type: 'application/zip' },
                        { name: 'sample_metadata.csv', size: '890 KB', type: 'text/csv' }
                    ]
                },
                {
                    id: 'data_002',
                    title: 'Real-World Evidence Database for Cancer Treatments',
                    type: 'database',
                    author: 'Dr. Jennifer Liu',
                    authorEmail: 'jennifer.liu@llab.com',
                    date: '2025-06-10',
                    content: `# Real-World Evidence Database for Cancer Treatments

## Introduction
Our Real-World Evidence (RWE) database aggregates treatment outcomes and patient experiences from over 200 cancer centers worldwide, providing insights into real-world treatment effectiveness beyond clinical trials.

## Database Scope
### Geographic Coverage
- **North America**: 85 cancer centers (US, Canada)
- **Europe**: 67 cancer centers (15 countries)
- **Asia-Pacific**: 48 cancer centers (8 countries)
- **Total Patients**: 125,000+ unique patients
- **Follow-up Period**: Up to 10 years per patient

### Cancer Types Covered
1. **Lung Cancer**: 23,500 patients
2. **Breast Cancer**: 28,700 patients
3. **Colorectal Cancer**: 19,200 patients
4. **Prostate Cancer**: 16,800 patients
5. **Melanoma**: 12,400 patients
6. **Other Types**: 24,400 patients

## Data Collection Framework
### Electronic Health Records
- **Treatment Protocols**: Detailed chemotherapy regimens
- **Imaging Results**: Response assessment scans
- **Laboratory Values**: Blood work and biomarkers
- **Adverse Events**: Side effects and complications
- **Hospitalizations**: Unplanned admissions and procedures

### Patient-Reported Outcomes
- **Quality of Life**: EORTC QLQ-C30 questionnaires
- **Symptom Tracking**: Daily symptom diaries
- **Functional Status**: Performance status assessments
- **Treatment Satisfaction**: Patient experience surveys
- **Financial Toxicity**: Cost-related distress measures

### Molecular Profiling
- **Tumor Sequencing**: Targeted gene panels and whole exome
- **Biomarker Testing**: PD-L1, MSI, TMB, HRD status
- **Liquid Biopsies**: Circulating tumor DNA monitoring
- **Pharmacogenomics**: Drug metabolism gene variants

## Data Analytics and Insights
### Treatment Effectiveness
- **Overall Survival**: Real-world vs. clinical trial outcomes
- **Progression-Free Survival**: Treatment duration analysis
- **Response Rates**: Objective response in real-world settings
- **Comparative Effectiveness**: Head-to-head treatment comparisons

### Predictive Modeling
- **ML Algorithms**: Random forests, gradient boosting, neural networks
- **Validation**: 5-fold cross-validation with holdout test sets
- **Performance Metrics**: C-index, calibration, discrimination
- **Clinical Utility**: Decision curve analysis

### Health Economics
- **Treatment Costs**: Direct medical expenses
- **Resource Utilization**: Healthcare service usage
- **Cost-Effectiveness**: QALY and ICER calculations
- **Budget Impact**: Population-level cost projections

## Key Findings
### Treatment Patterns
- **First-line Therapy**: 78% receive guideline-concordant care
- **Biomarker Testing**: 65% of eligible patients tested
- **Clinical Trial Participation**: Only 12% of patients enrolled
- **Treatment Switching**: Average 2.3 lines of therapy per patient

### Outcome Disparities
- **Geographic Variation**: 15% difference in survival across regions
- **Socioeconomic Factors**: Lower income associated with worse outcomes
- **Age-related Patterns**: Undertreatment in elderly patients
- **Rural vs. Urban**: Access challenges in rural areas

## Data Access and Collaboration
### Research Partnerships
- **Academic Institutions**: 45 university collaborations
- **Pharmaceutical Companies**: 12 industry partnerships
- **Regulatory Agencies**: FDA, EMA, Health Canada cooperation
- **Patient Organizations**: 8 advocacy group partnerships

### Data Sharing Protocols
- **Federated Queries**: Analysis without data movement
- **Summary Statistics**: Aggregated results sharing
- **Synthetic Data**: Privacy-preserving synthetic datasets
- **Secure Enclaves**: Controlled access for sensitive analyses`,
                    excerpt: 'Comprehensive real-world evidence database tracking cancer treatment outcomes from 200+ centers worldwide with 125,000+ patients.',
                    tags: ['real-world evidence', 'cancer outcomes', 'healthcare database', 'treatment effectiveness', 'health economics'],
                    likes: 178,
                    views: 2834,
                    downloads: 445,
                    shares: 89,
                    status: 'approved',
                    files: [
                        { name: 'rwe_database_schema.pdf', size: '3.2 MB', type: 'application/pdf' },
                        { name: 'query_examples.sql', size: '78 KB', type: 'text/sql' },
                        { name: 'api_documentation.html', size: '245 KB', type: 'text/html' }
                    ]
                },
                {
                    id: 'data_003',
                    title: 'Single-Cell RNA-seq Atlas of Human Tumor Microenvironment',
                    type: 'dataset',
                    author: 'International Cancer Genome Consortium',
                    authorEmail: 'icgc@llab.com',
                    date: '2025-06-08',
                    content: `# Single-Cell RNA-seq Atlas of Human Tumor Microenvironment

## Dataset Overview
This comprehensive single-cell RNA sequencing atlas provides unprecedented insight into the cellular composition and transcriptional landscape of the tumor microenvironment across 12 major cancer types.

## Data Composition
### Single-Cell Profiling
- **Total Cells**: 2.8 million individual cells
- **Cancer Types**: 12 major cancer types
- **Patients**: 1,847 unique patients
- **Tissue Sites**: Primary tumors, metastases, adjacent normal
- **Technology**: 10X Genomics Chromium platform

### Cell Type Annotation
- **Cancer Cells**: Malignant epithelial cells with CNV profiles
- **Immune Cells**: T cells, B cells, NK cells, macrophages, neutrophils
- **Stromal Cells**: Fibroblasts, endothelial cells, pericytes
- **Stem Cells**: Cancer stem cells and tissue-resident stem cells

### Quality Metrics
- **Median Genes per Cell**: 3,247
- **Median UMIs per Cell**: 8,942
- **Doublet Rate**: <5% across all samples
- **Mitochondrial Content**: <20% for included cells

## Analytical Features
### Dimensionality Reduction
- **PCA**: Principal component analysis with batch correction
- **UMAP**: Uniform manifold approximation and projection
- **t-SNE**: t-distributed stochastic neighbor embedding
- **Harmony**: Batch effect correction for multi-site data

### Cell Type Classification
- **Automated Annotation**: Using SingleR and CellTypist
- **Manual Curation**: Expert pathologist validation
- **Marker Genes**: Comprehensive marker gene databases
- **Confidence Scores**: Classification certainty metrics

### Trajectory Analysis
- **Pseudotime**: Cellular developmental trajectories
- **RNA Velocity**: Directional cell state transitions
- **Differentiation**: Stem cell to mature cell pathways
- **Metastasis**: Primary to metastatic cell evolution

## Research Applications
### Tumor Heterogeneity
- **Intratumor Diversity**: Cellular composition variability
- **Clonal Evolution**: Cancer cell evolutionary patterns
- **Spatial Organization**: Cell-cell interaction patterns
- **Treatment Response**: Therapy-induced changes

### Biomarker Discovery
- **Prognostic Markers**: Survival-associated cell populations
- **Predictive Markers**: Treatment response indicators
- **Resistance Mechanisms**: Drug resistance cell states
- **Immune Evasion**: Immunosuppressive cell types

### Drug Development
- **Target Identification**: Cell-type-specific therapeutic targets
- **Combination Therapy**: Multi-cell-type targeting strategies
- **Resistance Prediction**: Pre-treatment resistance markers
- **Efficacy Monitoring**: Treatment response assessment

## Data Access
### Download Options
- **Processed Data**: Cell x gene matrices (HDF5, CSV)
- **Raw Data**: FASTQ files via SRA accession
- **Metadata**: Clinical and technical annotations
- **Analysis Results**: Differential expression, pathway analysis

### Analysis Platforms
- **Seurat**: R-based single-cell analysis
- **Scanpy**: Python-based analysis toolkit
- **Cell Ranger**: 10X Genomics processing pipeline
- **CellxGene**: Interactive web-based exploration

### Quality Control
- **Batch Effects**: Comprehensive batch correction
- **Technical Artifacts**: Systematic error identification
- **Biological Validation**: Orthogonal validation methods
- **Reproducibility**: Analysis code and protocols provided`,
                    excerpt: 'Comprehensive single-cell RNA-seq atlas with 2.8M cells from tumor microenvironments across 12 cancer types, enabling deep analysis of cellular diversity and interactions.',
                    tags: ['single-cell', 'RNA-seq', 'tumor microenvironment', 'cancer', 'immune cells'],
                    likes: 412,
                    views: 5234,
                    downloads: 1847,
                    shares: 298,
                    status: 'approved',
                    files: [
                        { name: 'scrnaseq_atlas_metadata.csv', size: '45.7 MB', type: 'text/csv' },
                        { name: 'cell_annotations.h5ad', size: '12.3 GB', type: 'application/h5ad' },
                        { name: 'gene_expression_matrix.h5', size: '8.9 GB', type: 'application/h5' },
                        { name: 'analysis_protocols.pdf', size: '15.6 MB', type: 'application/pdf' },
                        { name: 'marker_genes.xlsx', size: '8.2 MB', type: 'application/excel' },
                        { name: 'quality_metrics.json', size: '125 KB', type: 'application/json' }
                    ]
                },
                {
                    id: 'data_004',
                    title: 'Longitudinal Multi-Omics Study of Cancer Treatment Response',
                    type: 'database',
                    author: 'Dr. Alexandra Peterson',
                    authorEmail: 'alexandra.p@llab.com',
                    date: '2025-06-06',
                    content: `# Longitudinal Multi-Omics Study of Cancer Treatment Response

## Study Design
This prospective longitudinal study tracks molecular changes in cancer patients throughout their treatment journey using integrated multi-omics profiling.

## Cohort Description
### Patient Demographics
- **Total Patients**: 4,567 cancer patients
- **Cancer Types**: Breast, lung, colorectal, prostate, melanoma
- **Treatment Centers**: 25 NCI-designated cancer centers
- **Follow-up Period**: Up to 5 years per patient
- **Geographic Coverage**: US, Europe, Asia-Pacific

### Treatment Protocols
- **Chemotherapy**: Standard and novel chemotherapy regimens
- **Immunotherapy**: PD-1/PD-L1, CAR-T, combination therapies
- **Targeted Therapy**: Small molecule inhibitors, monoclonal antibodies
- **Combination Treatments**: Multi-modal treatment approaches
- **Surgical Interventions**: Resection timing and outcomes

## Multi-Omics Profiling
### Genomic Analysis
- **Whole Exome Sequencing**: Tumor and germline variants
- **Copy Number Analysis**: Chromosomal alterations
- **Structural Variants**: Fusion genes and rearrangements
- **Tumor Mutational Burden**: Mutation density quantification
- **Microsatellite Instability**: MSI status determination

### Transcriptomic Profiling
- **Bulk RNA-seq**: Tumor and normal tissue expression
- **Single-cell RNA-seq**: Cellular heterogeneity analysis
- **Spatial Transcriptomics**: Tissue architecture mapping
- **Long-read Sequencing**: Isoform and fusion detection
- **Small RNA Profiling**: miRNA and lncRNA expression

### Epigenomic Analysis
- **DNA Methylation**: Genome-wide methylation patterns
- **Histone Modifications**: ChIP-seq for active/repressive marks
- **Chromatin Accessibility**: ATAC-seq open chromatin regions
- **3D Chromatin Structure**: Hi-C chromatin organization
- **Epigenetic Age**: Molecular aging biomarkers

### Proteomic Studies
- **Mass Spectrometry**: Global protein expression profiling
- **Phosphoproteomics**: Signaling pathway activation
- **Immunoproteomics**: HLA peptide presentation
- **Protein Arrays**: Targeted protein quantification
- **Tissue Imaging**: Spatial protein distribution

## Clinical Data Integration
### Treatment Response Monitoring
- **RECIST Criteria**: Radiological response assessment
- **Pathological Response**: Complete/partial response rates
- **Biomarker Tracking**: Circulating tumor DNA, proteins
- **Imaging Biomarkers**: Radiomics feature extraction
- **Quality of Life**: Patient-reported outcome measures

### Longitudinal Sampling
- **Baseline**: Pre-treatment molecular profiling
- **Early Response**: 2-4 weeks post-treatment initiation
- **Mid-treatment**: Treatment cycle midpoints
- **Post-treatment**: End of treatment assessment
- **Follow-up**: Long-term survival monitoring

### Adverse Event Tracking
- **Toxicity Grading**: CTCAE adverse event classification
- **Immune-related AEs**: Immunotherapy-specific toxicities
- **Dose Modifications**: Treatment adjustments and rationale
- **Hospitalizations**: Unplanned admissions and causes
- **Quality Metrics**: Treatment delivery adherence

## Computational Framework
### Data Processing
- **Standardized Pipelines**: Uniform processing across sites
- **Quality Control**: Multi-level QC and validation
- **Batch Correction**: Cross-site harmonization
- **Missing Data**: Imputation and sensitivity analysis
- **Data Integration**: Multi-omics data fusion methods

### Analysis Methods
- **Machine Learning**: Predictive modeling for treatment response
- **Network Analysis**: Molecular pathway reconstruction
- **Time Series Analysis**: Longitudinal pattern identification
- **Survival Analysis**: Time-to-event outcome modeling
- **Causal Inference**: Treatment effect estimation`,
                    excerpt: 'Longitudinal multi-omics study tracking molecular changes in 4,567 cancer patients throughout treatment, providing insights into response mechanisms.',
                    tags: ['longitudinal study', 'multi-omics', 'treatment response', 'precision medicine', 'biomarkers'],
                    likes: 356,
                    views: 4128,
                    downloads: 923,
                    shares: 167,
                    status: 'approved',
                    files: [
                        { name: 'study_protocol.pdf', size: '8.9 MB', type: 'application/pdf' },
                        { name: 'clinical_data_dictionary.xlsx', size: '12.5 MB', type: 'application/excel' },
                        { name: 'omics_processing_pipeline.md', size: '156 KB', type: 'text/markdown' },
                        { name: 'longitudinal_analysis_code.zip', size: '78.3 MB', type: 'application/zip' },
                        { name: 'sample_metadata.csv', size: '34.7 MB', type: 'text/csv' }
                    ]
                }
            ],
            Tools: [
                {
                    id: 'tools_001',
                    title: 'PathologyAI Pro: Deep Learning Toolkit for Digital Pathology',
                    type: 'software',
                    author: 'L-Lab Development Team',
                    authorEmail: 'dev@llab.com',
                    date: '2025-06-13',
                    content: `# PathologyAI Pro: Deep Learning Toolkit for Digital Pathology

## Overview
PathologyAI Pro is a comprehensive software toolkit that brings state-of-the-art deep learning capabilities to digital pathology workflows, enabling pathologists and researchers to leverage AI for accurate and efficient diagnosis.

## Key Features
### AI-Powered Analysis
- **Cancer Detection**: Automated tumor identification with 97.2% accuracy
- **Grading Systems**: Automated Gleason scoring for prostate cancer
- **Mutation Prediction**: Predict genetic mutations from H&E stains
- **Biomarker Quantification**: Automated IHC scoring and analysis
- **Quality Assessment**: Automatic slide quality evaluation

### User Interface
- **Web-based Platform**: No installation required, works in any browser
- **Drag & Drop**: Simple file upload for whole slide images
- **Real-time Processing**: Live analysis with progress indicators
- **Interactive Visualization**: Zoom, pan, and annotate results
- **Collaborative Features**: Share cases and annotations with colleagues

### Integration Capabilities
- **PACS Integration**: Direct connection to hospital imaging systems
- **LIS Connectivity**: Laboratory information system integration
- **API Access**: RESTful APIs for custom integrations
- **Batch Processing**: Automated analysis of large case volumes
- **Cloud Deployment**: AWS, Azure, and Google Cloud support

## Supported Applications
### Cancer Diagnosis
1. **Breast Cancer**
   - ER/PR/HER2 scoring
   - Ki-67 quantification
   - Tumor-infiltrating lymphocyte assessment
   - Ductal carcinoma in situ detection

2. **Prostate Cancer**
   - Gleason grading automation
   - Cribriform pattern recognition
   - Perineural invasion detection
   - Tertiary pattern identification

3. **Lung Cancer**
   - Histologic subtyping
   - PD-L1 expression scoring
   - ALK rearrangement prediction
   - Tumor mutation burden estimation

4. **Colorectal Cancer**
   - Microsatellite instability prediction
   - Tumor budding assessment
   - Lymph node metastasis detection
   - Mismatch repair protein status

### Research Applications
- **Drug Development**: Compound screening and efficacy assessment
- **Biomarker Discovery**: Novel marker identification and validation
- **Clinical Trials**: Automated endpoint assessment
- **Population Studies**: Large-scale epidemiological analysis

## Technical Specifications
### System Requirements
- **Minimum RAM**: 16 GB (32 GB recommended)
- **GPU**: NVIDIA GTX 1080 or better (RTX 3080 recommended)
- **Storage**: 1 TB SSD for local processing
- **Network**: High-speed internet for cloud processing
- **Browser**: Chrome, Firefox, Safari, or Edge (latest versions)

### Performance Benchmarks
- **Processing Speed**: 5-15 minutes per whole slide image
- **Accuracy**: >95% concordance with expert pathologists
- **Throughput**: 100+ slides per hour with cloud processing
- **Scalability**: Supports 1,000+ concurrent users
- **Uptime**: 99.9% availability SLA

### Security and Compliance
- **HIPAA Compliance**: Full healthcare data protection
- **SOC 2 Type II**: Annual security audits
- **Data Encryption**: AES-256 encryption at rest and in transit
- **Access Controls**: Role-based permissions and audit trails
- **Geographic Restrictions**: Data residency controls

## Getting Started
### Installation Options
1. **Cloud Version**: Instant access at pathologyai.llab.com
2. **On-Premise**: Docker containers for local deployment
3. **Hybrid**: Combine cloud processing with local data storage
4. **API Only**: Integrate AI capabilities into existing systems

### Training and Support
- **Interactive Tutorials**: Step-by-step guided workflows
- **Video Training**: Comprehensive training library
- **Documentation**: Detailed user guides and API references
- **Technical Support**: 24/7 support for enterprise customers
- **Community Forum**: User community and expert assistance

### Pricing
- **Academic**: Free for educational institutions
- **Startup**: $99/month for small research labs
- **Professional**: $499/month for clinical practices
- **Enterprise**: Custom pricing for large organizations
- **Pay-per-Use**: $5 per slide analysis for occasional users

## Validation and Publications
### Clinical Validation
- **Multi-center Studies**: Validated across 25 institutions
- **Regulatory Approval**: FDA 510(k) clearance pending
- **CAP Proficiency**: College of American Pathologists approved
- **International Standards**: ISO 13485 compliant

### Published Research
- 15+ peer-reviewed publications in Nature, Science, NEJM
- 50+ conference presentations at USCAP, ESP, AACR
- Featured in The Lancet Digital Health editorial
- Recognized with MICCAI Best Paper Award

## Future Roadmap
### Q3 2025 Release
- **Multi-stain Fusion**: Combine H&E and IHC analysis
- **3D Reconstruction**: Volumetric tissue analysis
- **Live Microscopy**: Real-time analysis during examination
- **Mobile App**: Tablet-optimized interface for pathologists

### Q4 2025 Release
- **Predictive Analytics**: Treatment outcome predictions
- **Federated Learning**: Collaborative model training
- **Augmented Reality**: AR-guided microscopy
- **Voice Commands**: Hands-free operation capabilities`,
                    excerpt: 'Professional-grade deep learning toolkit for digital pathology with 97.2% accuracy in cancer detection and comprehensive clinical integration.',
                    tags: ['digital pathology', 'deep learning', 'medical AI', 'cancer diagnosis', 'clinical software'],
                    likes: 312,
                    views: 4567,
                    downloads: 1234,
                    shares: 198,
                    status: 'approved',
                    files: [
                        { name: 'pathologyai_installer.exe', size: '156 MB', type: 'application/exe' },
                        { name: 'pathologyai_installer.dmg', size: '162 MB', type: 'application/dmg' },
                        { name: 'pathologyai_linux.tar.gz', size: '148 MB', type: 'application/gzip' },
                        { name: 'user_manual.pdf', size: '12.5 MB', type: 'application/pdf' },
                        { name: 'api_documentation.pdf', size: '8.9 MB', type: 'application/pdf' },
                        { name: 'sample_datasets.zip', size: '2.1 GB', type: 'application/zip' }
                    ]
                },
                {
                    id: 'tools_002',
                    title: 'GenomeAnalyzer: Comprehensive Genomic Data Analysis Suite',
                    type: 'software',
                    author: 'Dr. Kevin Zhang',
                    authorEmail: 'kevin.zhang@llab.com',
                    date: '2025-06-11',
                    content: `# GenomeAnalyzer: Comprehensive Genomic Data Analysis Suite

## Introduction
GenomeAnalyzer is an integrated bioinformatics platform that provides end-to-end genomic data analysis capabilities, from raw sequencing data processing to advanced population genetics and clinical interpretation.

## Core Modules
### Data Processing Pipeline
- **Quality Control**: FastQC, MultiQC, and custom QC metrics
- **Read Alignment**: BWA-MEM, Bowtie2, and STAR aligners
- **Variant Calling**: GATK HaplotypeCaller, FreeBayes, and Strelka2
- **Annotation**: VEP, ANNOVAR, and SnpEff integration
- **Filtering**: Advanced filtering based on quality, frequency, and impact

### Analysis Capabilities
1. **Single Sample Analysis**
   - Germline variant detection
   - Somatic mutation calling
   - Copy number variation analysis
   - Structural variant identification
   - Pharmacogenomic profiling

2. **Population Genetics**
   - GWAS analysis with association testing
   - Population stratification and PCA
   - Linkage disequilibrium analysis
   - Haplotype phasing and imputation
   - Selection pressure analysis

3. **Cancer Genomics**
   - Tumor-normal pair analysis
   - Mutation signature analysis
   - Oncogene and tumor suppressor identification
   - Microsatellite instability detection
   - Tumor mutation burden calculation

4. **Clinical Interpretation**
   - Pathogenicity prediction (CADD, SIFT, PolyPhen)
   - Clinical variant classification (ACMG guidelines)
   - Drug-gene interaction analysis
   - Disease risk assessment
   - Carrier screening reports

## Key Features
### Performance Optimization
- **Parallel Processing**: Multi-core CPU and GPU acceleration
- **Memory Efficiency**: Optimized algorithms for large datasets
- **Cloud Computing**: AWS, Google Cloud, and Azure integration
- **Scalability**: Process thousands of samples simultaneously
- **Containerization**: Docker and Singularity support

### User Interface
- **Command Line Interface**: Full scripting and automation support
- **Web Interface**: Browser-based analysis and visualization
- **R/Python Integration**: Custom analysis with popular languages
- **Jupyter Notebooks**: Interactive analysis environments
- **Workflow Management**: Nextflow and Snakemake integration

### Visualization Tools
- **Genome Browser**: Interactive genomic region exploration
- **Variant Plots**: Manhattan plots, Q-Q plots, and volcano plots
- **Phylogenetic Trees**: Population relationship visualization
- **Circos Plots**: Genome-wide structural variant display
- **Interactive Reports**: HTML reports with embedded visualizations

## Supported Data Types
### Sequencing Technologies
- **Illumina**: HiSeq, NovaSeq, MiSeq platforms
- **Oxford Nanopore**: Long-read sequencing analysis
- **PacBio**: Single-molecule real-time sequencing
- **Ion Torrent**: Semiconductor sequencing
- **BGI**: DNBSEQ and MGISEQ platforms

### File Formats
- **Input**: FASTQ, BAM, CRAM, VCF, GVCF
- **Output**: VCF, TSV, JSON, HTML reports
- **Databases**: dbSNP, ClinVar, gnomAD, COSMIC
- **Standards**: FHIR, GA4GH, FAIR compliance

## Clinical Applications
### Diagnostic Testing
- **Hereditary Cancer**: BRCA1/2, Lynch syndrome, Li-Fraumeni
- **Cardiovascular Disease**: Familial hypercholesterolemia, cardiomyopathy
- **Neurological Disorders**: Huntington's, ALS, epilepsy
- **Rare Diseases**: Whole exome and genome analysis
- **Pharmacogenomics**: Drug metabolism and response prediction

### Research Applications
- **Biomarker Discovery**: Novel variant identification
- **Drug Development**: Target validation and stratification
- **Clinical Trials**: Patient selection and outcome prediction
- **Population Health**: Large-scale epidemiological studies

## Quality Assurance
### Validation Studies
- **Accuracy**: >99.5% concordance with gold standard methods
- **Sensitivity**: 98.7% for SNVs, 95.2% for indels
- **Specificity**: 99.9% for high-quality variants
- **Reproducibility**: CV <2% across technical replicates
- **Benchmarking**: Regular participation in proficiency testing

### Regulatory Compliance
- **CAP/CLIA**: Laboratory accreditation standards
- **ISO 15189**: Medical laboratory quality management
- **FDA Guidance**: Compliance with regulatory frameworks
- **GDPR**: Data privacy and protection compliance
- **HIPAA**: Healthcare information security

## Installation and Deployment
### System Requirements
- **Operating System**: Linux (Ubuntu 18.04+, CentOS 7+)
- **CPU**: 8+ cores (32+ cores recommended)
- **RAM**: 32 GB minimum (128 GB recommended)
- **Storage**: 1 TB SSD (10 TB for large projects)
- **Network**: High-speed internet for database updates

### Deployment Options
1. **Standalone**: Single-server installation
2. **Cluster**: High-performance computing environments
3. **Cloud**: AWS, Azure, Google Cloud deployments
4. **Container**: Docker and Kubernetes orchestration
5. **Hybrid**: On-premise with cloud burst capabilities

### Licensing and Support
- **Academic License**: Free for educational institutions
- **Commercial License**: Tiered pricing based on usage
- **Enterprise Support**: 24/7 technical assistance
- **Training Programs**: Workshops and certification courses
- **Community**: Active user forum and documentation`,
                    excerpt: 'Comprehensive genomic analysis suite providing end-to-end capabilities from raw sequencing data to clinical interpretation with >99.5% accuracy.',
                    tags: ['genomics', 'bioinformatics', 'variant analysis', 'clinical interpretation', 'population genetics'],
                    likes: 245,
                    views: 3892,
                    downloads: 756,
                    shares: 123,
                    status: 'approved',
                    files: [
                        { name: 'genomeanalyzer_v2.5.tar.gz', size: '89 MB', type: 'application/gzip' },
                        { name: 'installation_guide.pdf', size: '5.4 MB', type: 'application/pdf' },
                        { name: 'user_manual.pdf', size: '18.7 MB', type: 'application/pdf' },
                        { name: 'sample_workflows.zip', size: '125 MB', type: 'application/zip' },
                        { name: 'test_datasets.tar.gz', size: '890 MB', type: 'application/gzip' }
                    ]
                },
                {
                    id: 'tools_003',
                    title: 'DeepSlide: AI-Powered Histopathology Analysis Platform',
                    type: 'software',
                    author: 'Dr. Maria Gonzalez',
                    authorEmail: 'maria.g@llab.com',
                    date: '2025-06-08',
                    content: `# DeepSlide: AI-Powered Histopathology Analysis Platform

## Overview
DeepSlide is an integrated deep learning platform specifically designed for histopathology image analysis, offering state-of-the-art models for cancer detection, grading, and biomarker prediction.

## Key Features
### Automated Analysis
- **Cancer Detection**: Automated tumor detection with 98.5% sensitivity
- **Gleason Grading**: Automated prostate cancer grading
- **HER2 Scoring**: Automated HER2 immunohistochemistry scoring
- **Ki-67 Quantification**: Proliferation index calculation

### Deep Learning Models
- **EfficientNet Architecture**: Optimized for pathology images
- **Attention Mechanisms**: Focus on diagnostically relevant regions
- **Multi-Scale Analysis**: Processes images at multiple magnifications
- **Ensemble Methods**: Combines multiple model predictions

### Workflow Integration
- **PACS Integration**: Direct connection to hospital systems
- **LIS Interface**: Laboratory information system compatibility
- **HL7 Support**: Healthcare data exchange standards
- **DICOM Compliance**: Medical imaging standards

## Performance Metrics
### Clinical Validation
- **Multi-site Validation**: Tested across 15 pathology laboratories
- **Sample Size**: 50,000+ histopathology slides
- **Concordance Rate**: 96.8% agreement with expert pathologists
- **Processing Speed**: <30 seconds per whole slide image

### Accuracy Metrics
- **Breast Cancer Detection**: 97.2% sensitivity, 95.8% specificity
- **Prostate Cancer Grading**: 94.5% concordance with pathologists
- **Lung Cancer Subtyping**: 93.1% classification accuracy
- **Skin Cancer Diagnosis**: 96.3% diagnostic accuracy

## Technical Specifications
### System Requirements
- **GPU**: NVIDIA RTX 3080 or higher
- **RAM**: 32GB minimum, 64GB recommended
- **Storage**: 1TB SSD for model cache
- **OS**: Windows 10/11, Ubuntu 18.04+, macOS 10.15+

### API Integration
- **REST API**: Full programmatic access
- **Python SDK**: Native Python library
- **Docker Support**: Containerized deployment
- **Cloud Deployment**: AWS, Azure, GCP compatibility`,
                    excerpt: 'Comprehensive AI platform for histopathology analysis with automated cancer detection, grading, and biomarker prediction capabilities.',
                    tags: ['pathology', 'AI', 'deep learning', 'cancer detection', 'image analysis'],
                    likes: 298,
                    views: 3847,
                    downloads: 567,
                    shares: 145,
                    rating: 4.9,
                    version: '3.2.1',
                    users: 1850,
                    status: 'approved',
                    files: [
                        { name: 'deepslide_installer.exe', size: '2.1 GB', type: 'application/exe' },
                        { name: 'deepslide_docker.tar.gz', size: '1.8 GB', type: 'application/gzip' },
                        { name: 'python_sdk.whl', size: '45 MB', type: 'application/wheel' },
                        { name: 'api_documentation.pdf', size: '12.3 MB', type: 'application/pdf' },
                        { name: 'validation_study.pdf', size: '8.7 MB', type: 'application/pdf' },
                        { name: 'demo_datasets.zip', size: '500 MB', type: 'application/zip' }
                    ]
                },
                {
                    id: 'tools_004',
                    title: 'BioViz: Interactive Data Visualization for Omics Research',
                    type: 'software',
                    author: 'Dr. James Wilson',
                    authorEmail: 'james.w@llab.com',
                    date: '2025-06-05',
                    content: `# BioViz: Interactive Data Visualization for Omics Research

## Introduction
BioViz is a powerful, web-based visualization platform designed specifically for multi-omics data exploration and analysis in biomedical research.

## Visualization Types
### Genomics Visualizations
- **Genome Browser**: Interactive chromosome and gene visualization
- **Circos Plots**: Genome-wide structural variant display
- **Manhattan Plots**: GWAS results visualization
- **Heatmaps**: Gene expression and methylation patterns

### Proteomics & Metabolomics
- **Pathway Networks**: Interactive biochemical pathway maps
- **Volcano Plots**: Differential expression visualization
- **PCA/t-SNE Plots**: Dimensionality reduction and clustering
- **Time Series**: Longitudinal data visualization

### Clinical Data Integration
- **Survival Curves**: Kaplan-Meier survival analysis
- **Forest Plots**: Meta-analysis and clinical trial results
- **Box Plots**: Biomarker distribution analysis
- **Correlation Matrices**: Multi-parameter association analysis

## Interactive Features
### Real-time Analysis
- **Dynamic Filtering**: Real-time data subsetting
- **Brush Selection**: Interactive data point selection
- **Zoom & Pan**: Seamless navigation of large datasets
- **Linked Views**: Synchronized multi-panel displays

### Collaboration Tools
- **Shared Workspaces**: Team collaboration features
- **Annotation System**: Collaborative data annotation
- **Export Options**: High-quality figure generation
- **Version Control**: Analysis history tracking

## Data Integration
### Supported Formats
- **Genomics**: VCF, BED, GFF, FASTA
- **Expression**: CSV, TSV, Excel, HDF5
- **Clinical**: OMOP CDM, HL7 FHIR
- **Images**: TIFF, SVS, DICOM

### Database Connectivity
- **Public Databases**: TCGA, GTEx, UK Biobank
- **Cloud Storage**: AWS S3, Google Cloud, Azure
- **Local Files**: Direct file upload and processing
- **APIs**: RESTful data source integration`,
                    excerpt: 'Interactive web-based platform for multi-omics data visualization with real-time analysis and collaboration features.',
                    tags: ['visualization', 'omics', 'data analysis', 'web platform', 'collaboration'],
                    likes: 234,
                    views: 2156,
                    downloads: 445,
                    shares: 89,
                    rating: 4.6,
                    version: '2.1.0',
                    users: 1200,
                    status: 'approved',
                    files: [
                        { name: 'bioviz_webapp.zip', size: '125 MB', type: 'application/zip' },
                        { name: 'docker-compose.yml', size: '5.2 KB', type: 'text/yaml' },
                        { name: 'user_guide.pdf', size: '15.6 MB', type: 'application/pdf' },
                        { name: 'api_reference.html', size: '8.9 MB', type: 'text/html' },
                        { name: 'sample_data.tar.gz', size: '2.3 GB', type: 'application/gzip' }
                    ]
                }
            ],
            About: [
                {
                    id: 'about_001',
                    title: 'L-Lab Research Platform: Mission and Vision',
                    type: 'information',
                    author: 'L-Lab Leadership Team',
                    authorEmail: 'leadership@llab.com',
                    date: '2025-06-16',
                    content: `# L-Lab Research Platform: Mission and Vision

## Our Mission
To accelerate biomedical discovery and improve human health through cutting-edge computational biology, artificial intelligence, and collaborative research platforms that democratize access to advanced scientific tools and knowledge.

## Vision Statement
We envision a future where every researcher, clinician, and institution has access to state-of-the-art computational tools and collaborative platforms that enable breakthrough discoveries in precision medicine, ultimately leading to better patient outcomes and global health equity.

## Core Values
### Scientific Excellence
- **Rigorous Methodology**: All research follows the highest scientific standards
- **Peer Review**: Transparent and thorough evaluation of all contributions
- **Reproducibility**: Open science practices and reproducible research
- **Innovation**: Pushing the boundaries of what's possible in biomedical research

### Collaboration and Openness
- **Open Science**: Commitment to open-source tools and open data
- **Global Collaboration**: Facilitating international research partnerships
- **Knowledge Sharing**: Free access to educational resources and training
- **Community Building**: Fostering inclusive research communities

### Ethical Research
- **Patient Privacy**: Strict adherence to data protection regulations
- **Informed Consent**: Transparent communication about data usage
- **Equity and Inclusion**: Ensuring diverse representation in research
- **Responsible AI**: Ethical development and deployment of AI technologies

## Research Focus Areas
### Computational Biology
- **Genomics**: Large-scale genomic analysis and interpretation
- **Transcriptomics**: RNA expression analysis and regulation
- **Proteomics**: Protein structure and function prediction
- **Systems Biology**: Multi-omics integration and pathway analysis
- **Evolutionary Biology**: Comparative genomics and phylogenetics

### Artificial Intelligence in Healthcare
- **Medical Imaging**: Deep learning for diagnostic imaging
- **Clinical Decision Support**: AI-powered treatment recommendations
- **Drug Discovery**: Machine learning for therapeutic development
- **Predictive Medicine**: Risk assessment and outcome prediction
- **Natural Language Processing**: Clinical text analysis and extraction

### Digital Health and Precision Medicine
- **Biomarker Discovery**: Novel therapeutic and diagnostic markers
- **Personalized Treatment**: Tailored therapy based on individual profiles
- **Real-World Evidence**: Large-scale outcome studies
- **Health Disparities**: Addressing equity in healthcare access
- **Population Health**: Community-based health interventions

## Platform Capabilities
### Research Infrastructure
- **High-Performance Computing**: Scalable computational resources
- **Data Storage**: Secure, FAIR-compliant data repositories
- **Analysis Pipelines**: Standardized, validated analysis workflows
- **Collaboration Tools**: Real-time research collaboration platforms
- **Quality Assurance**: Rigorous validation and testing frameworks

### Educational Resources
- **Online Courses**: Comprehensive training in computational biology
- **Workshops**: Hands-on training in latest tools and methods
- **Mentorship Programs**: Expert guidance for early-career researchers
- **Conference Proceedings**: Access to latest research presentations
- **Best Practices**: Guidelines for reproducible research

### Community Features
- **Discussion Forums**: Expert advice and peer support
- **Project Collaboration**: Multi-institutional research projects
- **Resource Sharing**: Datasets, tools, and computational resources
- **Publication Support**: Assistance with manuscript preparation
- **Networking**: Connect with researchers worldwide

## Impact and Achievements
### Research Outcomes
- **Publications**: 500+ peer-reviewed papers published
- **Citations**: 25,000+ citations of platform-enabled research
- **Collaborations**: 200+ institutions across 50 countries
- **Users**: 10,000+ active researchers and clinicians
- **Projects**: 1,500+ completed research projects

### Clinical Translation
- **FDA Approvals**: 5 diagnostic tools approved for clinical use
- **Clinical Trials**: 25+ trials using platform-developed biomarkers
- **Patient Impact**: 100,000+ patients benefited from research
- **Guidelines**: Contributed to 15 clinical practice guidelines
- **Partnerships**: 50+ pharmaceutical and biotechnology collaborations

### Technology Development
- **Open Source Tools**: 100+ freely available software packages
- **Databases**: 20+ curated biological databases
- **Standards**: Contributed to 10+ international data standards
- **Patents**: 25 patents filed for novel technologies
- **Spin-offs**: 8 startup companies founded by platform alumni

## Governance and Leadership
### Scientific Advisory Board
- **Dr. Jennifer Smith** - Chair, Harvard Medical School
- **Prof. Michael Chen** - Stanford University
- **Dr. Sarah Johnson** - Memorial Sloan Kettering Cancer Center
- **Prof. David Rodriguez** - University of Cambridge
- **Dr. Lisa Wang** - Mayo Clinic

### Executive Team
- **CEO**: Dr. Alex Thompson, MD, PhD
- **CTO**: Prof. Maria Garcia, PhD
- **Head of Research**: Dr. James Wilson, PhD
- **Head of Data Science**: Dr. Priya Patel, PhD
- **Head of Partnerships**: Dr. Robert Lee, MD

### Ethics Committee
- **Chair**: Prof. Catherine Brown, JD, PhD (Bioethics)
- **Members**: Representatives from medicine, law, ethics, and patient advocacy
- **Responsibilities**: Oversight of research ethics and data governance
- **Meetings**: Monthly review of projects and policies

## Funding and Sustainability
### Current Funding
- **NIH Grants**: $15M in active federal funding
- **Private Foundations**: $8M from Gates, Chan Zuckerberg, and others
- **Industry Partnerships**: $12M in collaborative agreements
- **Institutional Support**: $5M annual commitment from host institutions
- **User Subscriptions**: $3M annual revenue from premium services

### Future Plans
- **Expansion**: Scale to 50,000 users by 2027
- **New Platforms**: Launch precision medicine and rare disease platforms
- **Global Reach**: Establish regional hubs in Asia, Europe, and Africa
- **Technology Transfer**: Increase commercial partnerships and licensing
- **Sustainability**: Achieve financial sustainability through diversified revenue

## Join Our Community
### For Researchers
- **Register**: Create a free account at llab.com/register
- **Explore**: Browse tools, datasets, and educational resources
- **Contribute**: Share your data, tools, and expertise
- **Collaborate**: Connect with researchers in your field
- **Learn**: Take courses and attend workshops

### For Institutions
- **Partnership**: Institutional membership programs available
- **Training**: Custom training programs for your researchers
- **Consulting**: Expert consultation on computational biology projects
- **Licensing**: Access to proprietary tools and databases
- **Collaboration**: Joint research and development opportunities

### For Industry
- **Partnerships**: Collaborative research and development agreements
- **Licensing**: Access to cutting-edge technologies and IP
- **Consulting**: Expert advice on biomedical AI and data science
- **Talent**: Access to world-class computational biologists
- **Innovation**: Co-development of next-generation tools and platforms`,
                    excerpt: 'Learn about L-Lab\'s mission to democratize access to computational biology tools, our research focus areas, and how to join our global community of researchers.',
                    tags: ['mission', 'vision', 'research platform', 'computational biology', 'collaboration'],
                    likes: 456,
                    views: 5678,
                    downloads: 234,
                    shares: 189,
                    status: 'approved',
                    files: [
                        { name: 'llab_annual_report_2025.pdf', size: '8.9 MB', type: 'application/pdf' },
                        { name: 'partnership_opportunities.pdf', size: '2.3 MB', type: 'application/pdf' },
                        { name: 'researcher_handbook.pdf', size: '5.6 MB', type: 'application/pdf' }
                    ]
                },
                {
                    id: 'about_002',
                    title: 'Research Team and Leadership',
                    type: 'information',
                    author: 'L-Lab Human Resources',
                    authorEmail: 'hr@llab.com',
                    date: '2025-06-14',
                    content: `# Research Team and Leadership

## Leadership Team

### Dr. Lei Cao - Principal Investigator & Director
**Background**: Dr. Cao leads L-Lab's research initiatives with over 15 years of experience in computational biology and AI-driven biomedical research. He received his Ph.D. in Computational Biology from MIT and completed postdoctoral training at Stanford Medicine.

**Research Focus**:
- Digital pathology and AI-powered diagnostics
- Multi-omics data integration for precision medicine
- Machine learning applications in cancer research
- Collaborative research platform development

**Notable Achievements**:
- Published 150+ peer-reviewed papers (h-index: 67)
- Recipient of the NIH Early Career Investigator Award
- Named to MIT Technology Review's Innovators Under 35
- Lead developer of PathologyAI platform (used by 500+ institutions)

### Dr. Sarah Chen - Deputy Director of Research
**Background**: Dr. Chen specializes in cancer genomics and biomarker discovery. She earned her Ph.D. from Harvard Medical School and has 12 years of experience in translational cancer research.

**Research Focus**:
- Cancer biomarker discovery and validation
- Federated learning for medical AI
- Clinical trial design and optimization
- Regulatory science and AI in healthcare

**Key Contributions**:
- Discovered 23 novel cancer biomarkers currently in clinical trials
- Co-authored Nature paper on federated learning in medicine (2,100+ citations)
- Advisory board member for FDA AI/ML working group
- Founder of Women in Computational Biology initiative

### Dr. Michael Rodriguez - Chief Technology Officer
**Background**: Dr. Rodriguez oversees L-Lab's technology infrastructure and platform development. He holds a Ph.D. in Computer Science from Carnegie Mellon and was previously a Senior Research Scientist at Google DeepMind.

**Technical Expertise**:
- Large-scale distributed computing systems
- Cloud-native application architecture
- AI/ML infrastructure and MLOps
- Data security and privacy-preserving technologies

**Platform Development**:
- Architected L-Lab's federated learning infrastructure
- Developed privacy-preserving data sharing protocols
- Led implementation of HIPAA-compliant cloud systems
- Created automated ML pipeline for biomarker discovery

## Core Research Teams

### Computational Biology Group (15 researchers)
**Team Lead**: Dr. Elena Vasquez, Ph.D. in Bioinformatics

**Research Areas**:
- Single-cell genomics and spatial transcriptomics
- Systems biology and network analysis
- Evolutionary genomics and phylogenetics
- Computational structural biology

**Recent Publications**:
- "Single-cell atlas of tumor microenvironment heterogeneity" - Cell (2025)
- "Network-based drug repurposing for cancer therapy" - Nature Medicine (2024)
- "Evolutionary dynamics of tumor progression" - Science (2024)

### AI and Machine Learning Group (12 researchers)
**Team Lead**: Dr. James Wilson, Ph.D. in Machine Learning

**Research Focus**:
- Deep learning for medical image analysis
- Natural language processing for clinical text
- Explainable AI for healthcare applications
- Federated learning and privacy-preserving ML

**Technology Development**:
- DeepPathology: AI platform for histopathology analysis
- ClinicalNLP: Natural language processing for clinical notes
- FedMed: Federated learning framework for medical AI
- ExplainAI: Interpretable machine learning toolkit

### Digital Pathology Group (10 researchers)
**Team Lead**: Dr. Maria Gonzalez, M.D., Ph.D.

**Clinical Expertise**:
- Histopathology and cytopathology
- Digital imaging and telepathology
- Quality assurance and standardization
- Clinical workflow integration

**Innovations**:
- Developed automated Gleason scoring system (FDA approved)
- Created digital pathology quality metrics standards
- Pioneered AI-assisted pathology education platform
- Established telepathology consultation network

### Data Science and Engineering Group (8 researchers)
**Team Lead**: Dr. Kevin Zhang, Ph.D. in Data Science

**Technical Capabilities**:
- Big data analytics and visualization
- Cloud computing and DevOps
- Database design and optimization
- Real-time data processing systems

**Infrastructure Projects**:
- Multi-petabyte biomedical data lake
- Real-time analytics dashboard for clinical trials
- Automated data quality monitoring systems
- Scalable visualization platform for omics data

## Collaborative Networks

### Academic Partnerships
- **Harvard Medical School**: Joint research program in precision oncology
- **Stanford University**: Collaborative AI research initiative
- **MIT**: Technology transfer and commercialization program
- **Johns Hopkins**: Clinical validation studies
- **University of Pennsylvania**: Digital pathology consortium

### Industry Collaborations
- **Google Health**: AI for medical imaging research
- **Microsoft Research**: Cloud computing and AI infrastructure
- **NVIDIA**: GPU computing and AI acceleration
- **Illumina**: Genomics data analysis platforms
- **Roche**: Companion diagnostics development

### International Networks
- **European Cancer Organization**: Multi-site clinical studies
- **Asian Pacific Organization for Cancer Prevention**: Regional research initiatives
- **Canadian BioSample Repository Network**: Data sharing agreements
- **Australian Centre for Precision Health**: Joint methodology development

## Training and Education

### Graduate Student Program
- Ph.D. students: 25 current students
- Master's students: 15 current students
- Average graduation time: 4.5 years (Ph.D.), 2 years (M.S.)
- Placement rate: 95% in academia or industry positions

### Postdoctoral Fellowship Program
- Current postdocs: 18 fellows
- International fellows: 12 from 8 countries
- Average fellowship duration: 2.5 years
- Career advancement: 78% secure faculty or senior industry positions

### Visiting Scholar Program
- Annual visitors: 30-40 researchers
- Partner institutions: 45 universities worldwide
- Exchange duration: 3-12 months
- Research collaboration rate: 85% continue collaborative projects

### Professional Development
- Annual research symposium (500+ attendees)
- Monthly seminar series with external speakers
- Technical workshops and training sessions
- Career mentorship program for early-career researchers`,
                    excerpt: 'Comprehensive overview of L-Lab\'s research team, leadership, collaborative networks, and training programs spanning 50+ researchers across multiple disciplines.',
                    tags: ['team', 'leadership', 'collaboration', 'training', 'expertise'],
                    likes: 145,
                    views: 2341,
                    downloads: 234,
                    shares: 67,
                    status: 'approved',
                    files: [
                        { name: 'team_directory_2025.pdf', size: '4.2 MB', type: 'application/pdf' },
                        { name: 'organizational_chart.png', size: '856 KB', type: 'image/png' },
                        { name: 'collaboration_map.pdf', size: '2.1 MB', type: 'application/pdf' },
                        { name: 'training_programs.pdf', size: '3.8 MB', type: 'application/pdf' }
                    ]
                },
                {
                    id: 'about_003',
                    title: 'Research Impact and Publications',
                    type: 'information',
                    author: 'L-Lab Communications',
                    authorEmail: 'communications@llab.com',
                    date: '2025-06-12',
                    content: `# Research Impact and Publications

## Publication Metrics (2020-2025)

### Peer-Reviewed Publications
- **Total Publications**: 347 peer-reviewed articles
- **High-Impact Journals**: 156 publications in journals with IF > 10
- **First/Senior Author**: 234 publications with L-Lab as lead institution
- **Collaborative Studies**: 113 multi-institutional collaborations
- **Open Access**: 289 publications (83%) available open access

### Journal Distribution
#### Top-Tier Journals (Impact Factor > 20)
- **Nature**: 8 publications
- **Science**: 6 publications
- **Cell**: 12 publications
- **Nature Medicine**: 15 publications
- **Nature Biotechnology**: 9 publications
- **New England Journal of Medicine**: 4 publications

#### Specialized Journals
- **Nature Methods**: 23 publications
- **Genome Biology**: 18 publications
- **Bioinformatics**: 31 publications
- **Journal of Clinical Oncology**: 19 publications
- **Clinical Cancer Research**: 24 publications

### Citation Impact
- **Total Citations**: 45,678 citations
- **H-Index**: 89 (institutional)
- **Average Citations per Paper**: 132
- **Highly Cited Papers**: 45 papers with >500 citations
- **Hot Papers**: 12 papers in top 1% of field

## Research Grants and Funding

### Federal Funding (2020-2025)
- **NIH Grants**: $47.8 million total funding
  - R01 Grants: 15 awards ($32.1 million)
  - R21 Grants: 8 awards ($4.2 million)
  - SBIR/STTR: 6 awards ($3.7 million)
  - Training Grants: 4 awards ($7.8 million)

- **NSF Grants**: $12.4 million total funding
  - Major Research Instrumentation: $3.2 million
  - Collaborative Research: $6.8 million
  - CAREER Awards: 3 awards ($2.4 million)

- **DOD/DARPA**: $8.9 million
  - Applied Research: $5.6 million
  - Technology Development: $3.3 million

### Private Foundation Support
- **Gates Foundation**: $15.2 million (global health initiatives)
- **Chan Zuckerberg Initiative**: $8.7 million (single-cell research)
- **American Cancer Society**: $4.5 million (cancer research)
- **Susan G. Komen Foundation**: $2.8 million (breast cancer research)

### Industry Partnerships
- **Pharmaceutical Companies**: $23.6 million in collaborative research
- **Technology Companies**: $18.9 million in joint development projects
- **Diagnostic Companies**: $12.4 million in validation studies
- **Biotechnology Startups**: $7.2 million in sponsored research

## Awards and Recognition

### Institutional Awards
- **NIH Director's Pioneer Award** (2023): Dr. Lei Cao
- **Presidential Early Career Award** (2022): Dr. Sarah Chen
- **Technology Review Innovators Under 35** (2021): Dr. Michael Rodriguez
- **Forbes 30 Under 30** (2024): Dr. Elena Vasquez

### Research Excellence Awards
- **Best Paper Award - MICCAI 2024**: "Federated Learning for Medical Image Analysis"
- **Outstanding Research Award - AMIA 2023**: "AI-Powered Clinical Decision Support"
- **Innovation Prize - ASCO 2022**: "Precision Oncology Platform"
- **Excellence in Collaboration - NIH 2025**: Multi-institutional cancer genomics project

### Patent Portfolio
- **Issued Patents**: 67 US patents, 89 international patents
- **Pending Applications**: 34 patent applications under review
- **Licensing Revenue**: $8.7 million from technology licensing
- **Startup Formation**: 6 spin-off companies formed

## Community Impact

### Open Source Contributions
- **Software Packages**: 45 open-source tools and libraries
- **GitHub Stars**: 23,000+ stars across repositories
- **Downloads**: 2.1 million software downloads
- **Community Contributors**: 340+ external contributors

### Data Sharing Initiatives
- **Public Datasets**: 23 datasets shared with research community
- **Data Downloads**: 1.8 million dataset downloads
- **API Usage**: 50,000+ API calls per month
- **Research Studies**: 890+ studies using L-Lab shared data

### Educational Impact
- **Course Development**: 12 online courses (45,000+ students)
- **Workshop Training**: 156 workshops (8,900+ participants)
- **Webinar Series**: 78 webinars (67,000+ attendees)
- **Educational Resources**: 234 tutorials and documentation pages

### Clinical Translation
- **FDA Approvals**: 4 AI diagnostic tools approved
- **Clinical Trials**: 23 ongoing clinical validation studies
- **Hospital Deployments**: 156 hospitals using L-Lab technology
- **Patient Impact**: 45,000+ patients benefited from L-Lab innovations

## Future Directions

### Strategic Research Priorities (2025-2030)
1. **Precision Medicine**: Expanding personalized treatment algorithms
2. **Global Health**: Democratizing AI healthcare tools worldwide
3. **Preventive Medicine**: Early detection and intervention strategies
4. **Aging Research**: Computational approaches to healthy aging
5. **Mental Health**: AI applications in psychiatry and neurology

### Technology Development Goals
- **Next-Generation AI**: Advanced foundation models for biomedicine
- **Quantum Computing**: Exploring quantum algorithms for drug discovery
- **Augmented Reality**: AR/VR applications in medical education
- **Blockchain**: Secure, decentralized health data systems
- **Internet of Things**: Wearable sensors for continuous health monitoring

### Collaboration Expansion
- **International Partnerships**: New collaborations in Africa, South America
- **Industry Integration**: Deeper partnerships with healthcare systems
- **Regulatory Engagement**: Working with FDA, EMA on AI guidelines
- **Standards Development**: Contributing to international AI standards
- **Ethics Leadership**: Advancing responsible AI in healthcare`,
                    excerpt: 'Comprehensive overview of L-Lab\'s research impact including 347 publications, $130M+ in funding, 67 patents, and significant clinical translation achievements.',
                    tags: ['impact', 'publications', 'grants', 'awards', 'translation'],
                    likes: 234,
                    views: 3456,
                    downloads: 445,
                    shares: 123,
                    status: 'approved',
                    files: [
                        { name: 'publications_list_2025.pdf', size: '12.3 MB', type: 'application/pdf' },
                        { name: 'impact_metrics_dashboard.html', size: '2.8 MB', type: 'text/html' },
                        { name: 'grant_portfolio_summary.xlsx', size: '4.5 MB', type: 'application/excel' },
                        { name: 'patent_portfolio.pdf', size: '8.9 MB', type: 'application/pdf' },
                        { name: 'clinical_impact_report.pdf', size: '6.7 MB', type: 'application/pdf' }
                    ]
                },
                {
                    id: 'about_004',
                    title: 'Technology Infrastructure and Capabilities',
                    type: 'information',
                    author: 'L-Lab IT Department',
                    authorEmail: 'it@llab.com',
                    date: '2025-06-10',
                    content: `# Technology Infrastructure and Capabilities

## Computing Infrastructure

### High-Performance Computing (HPC)
- **CPU Cores**: 50,000+ CPU cores across multiple clusters
- **GPU Computing**: 1,200+ NVIDIA A100/H100 GPUs for AI workloads
- **Memory**: 200+ TB total RAM across computing nodes
- **Storage**: 50+ PB of high-performance storage systems
- **Network**: 100 Gbps InfiniBand interconnect for low-latency communication

### Cloud Computing Platforms
- **Multi-Cloud Strategy**: AWS, Google Cloud, Microsoft Azure
- **Hybrid Architecture**: Seamless workload distribution
- **Auto-Scaling**: Dynamic resource allocation based on demand
- **Cost Optimization**: Advanced cost monitoring and optimization
- **Compliance**: HIPAA, GDPR, and SOC 2 Type II compliant

### Specialized Hardware
- **Quantum Computing**: IBM Quantum Network member with cloud access
- **Bioinformatics Appliances**: Oxford Nanopore GridION, Illumina NovaSeq
- **AI Accelerators**: Google TPUs, Intel Habana Gaudi processors
- **Edge Computing**: NVIDIA Jetson devices for real-time inference
- **Custom ASIC**: Developing specialized chips for genomic analysis

## Data Management Systems

### Data Lake Architecture
- **Multi-Petabyte Storage**: Scalable object storage for diverse data types
- **Data Catalog**: Automated metadata discovery and lineage tracking
- **Version Control**: Complete data versioning and audit trails
- **Access Control**: Fine-grained permissions and data governance
- **Search Capabilities**: Full-text and semantic search across datasets

### Database Technologies
- **Relational Databases**: PostgreSQL, MySQL for structured clinical data
- **NoSQL Databases**: MongoDB, Cassandra for flexible schema requirements
- **Graph Databases**: Neo4j for network analysis and knowledge graphs
- **Time-Series Databases**: InfluxDB for sensor and monitoring data
- **Vector Databases**: Pinecone, Weaviate for similarity search and embeddings

### Real-Time Processing
- **Stream Processing**: Apache Kafka, Apache Flink for real-time analytics
- **Message Queues**: RabbitMQ, Amazon SQS for asynchronous processing
- **Event-Driven Architecture**: Microservices with event sourcing
- **API Gateway**: Kong, AWS API Gateway for service orchestration
- **Load Balancing**: NGINX, HAProxy for high availability

## AI/ML Platform

### Machine Learning Operations (MLOps)
- **Model Development**: JupyterHub, MLflow for experiment tracking
- **Model Training**: Kubernetes-based distributed training
- **Model Deployment**: Docker containers with Kubernetes orchestration
- **Model Monitoring**: Real-time performance monitoring and drift detection
- **A/B Testing**: Controlled deployment and performance comparison

### Deep Learning Frameworks
- **TensorFlow**: Primary framework for medical image analysis
- **PyTorch**: Research and development of novel architectures
- **JAX**: High-performance computing for large-scale training
- **ONNX**: Model interoperability and deployment optimization
- **Hugging Face**: Transformer models for natural language processing

### Specialized AI Tools
- **Computer Vision**: OpenCV, PIL, scikit-image for image processing
- **Natural Language**: spaCy, NLTK, transformers for text analysis
- **Genomics**: GATK, Bioconductor, scikit-bio for sequence analysis
- **Visualization**: Plotly, D3.js, Observable for interactive dashboards
- **Federated Learning**: PySyft, FATE for privacy-preserving ML

## Security and Compliance

### Cybersecurity Measures
- **Zero Trust Architecture**: Identity-based security model
- **Multi-Factor Authentication**: Required for all system access
- **Encryption**: AES-256 encryption at rest and in transit
- **Network Segmentation**: Isolated environments for sensitive data
- **Threat Detection**: AI-powered security monitoring and response

### Compliance Frameworks
- **HIPAA Compliance**: Healthcare data protection requirements
- **GDPR Compliance**: European data privacy regulations
- **SOC 2 Type II**: Annual security audits and certifications
- **FedRAMP**: Federal cloud security standards
- **ISO 27001**: Information security management systems

### Data Privacy Technologies
- **Differential Privacy**: Mathematical privacy guarantees
- **Homomorphic Encryption**: Computation on encrypted data
- **Secure Multi-Party Computation**: Collaborative analysis without data sharing
- **Federated Learning**: Decentralized model training
- **Data Anonymization**: Advanced techniques for data de-identification

## Development and Collaboration Tools

### Software Development
- **Version Control**: Git with GitLab for code management
- **CI/CD Pipelines**: Automated testing and deployment
- **Code Quality**: SonarQube, CodeClimate for code analysis
- **Documentation**: Sphinx, GitBook for technical documentation
- **Package Management**: Conda, pip, npm for dependency management

### Collaboration Platforms
- **Project Management**: Jira, Asana for project tracking
- **Communication**: Slack, Microsoft Teams for team collaboration
- **Video Conferencing**: Zoom, Google Meet for remote meetings
- **File Sharing**: Google Drive, Dropbox for document collaboration
- **Knowledge Management**: Confluence, Notion for institutional knowledge

### Research Tools
- **Literature Management**: Zotero, Mendeley for reference management
- **Notebook Platforms**: Jupyter, Observable for interactive analysis
- **Workflow Management**: Nextflow, Snakemake for reproducible pipelines
- **Data Visualization**: Tableau, Power BI for business intelligence
- **Statistical Analysis**: R, Python, STATA for statistical computing

## Innovation and Future Technologies

### Emerging Technologies
- **Quantum Machine Learning**: Exploring quantum advantages for optimization
- **Neuromorphic Computing**: Brain-inspired computing architectures
- **Photonic Computing**: Optical processors for AI acceleration
- **DNA Storage**: Exploring DNA as a data storage medium
- **Blockchain**: Decentralized systems for data integrity and sharing

### Research and Development
- **Internal R&D Budget**: $5.2 million annually for technology innovation
- **Patent Applications**: 15-20 technology patents filed annually
- **Proof of Concepts**: 25+ prototypes developed yearly
- **Technology Transfer**: Active licensing and commercialization program
- **Startup Incubation**: Supporting spin-off company formation

### Sustainability Initiatives
- **Green Computing**: Energy-efficient hardware and carbon-neutral cloud
- **Renewable Energy**: Solar panels and wind power for data centers
- **Waste Reduction**: Electronic waste recycling and refurbishment programs
- **Remote Work**: Reduced carbon footprint through flexible work arrangements
- **Sustainable Procurement**: Environmentally conscious vendor selection`,
                    excerpt: 'Comprehensive overview of L-Lab\'s technology infrastructure including 50K+ CPU cores, 1,200+ GPUs, 50+ PB storage, and advanced AI/ML platforms.',
                    tags: ['infrastructure', 'technology', 'computing', 'AI platform', 'security'],
                    likes: 178,
                    views: 2845,
                    downloads: 356,
                    shares: 89,
                    status: 'approved',
                    files: [
                        { name: 'infrastructure_overview.pdf', size: '15.6 MB', type: 'application/pdf' },
                        { name: 'architecture_diagrams.zip', size: '23.4 MB', type: 'application/zip' },
                        { name: 'security_compliance_report.pdf', size: '8.9 MB', type: 'application/pdf' },
                        { name: 'technology_roadmap.pptx', size: '12.7 MB', type: 'application/powerpoint' }
                    ]
                }
            ]
        };
        
        // Only initialize if no existing data
        const existingData = this.getAllContent();
        const isEmpty = Object.keys(existingData).length === 0 || 
                       Object.values(existingData).every(section => section.length === 0);
        
        if (isEmpty) {
            localStorage.setItem(this.storageKey, JSON.stringify(sampleData));
        }
    }
    
    getAllContent() {
        const data = localStorage.getItem(this.storageKey);
        return data ? JSON.parse(data) : {};
    }
    
    getContentBySection(section) {
        const allContent = this.getAllContent();
        return allContent[section] || [];
    }
    
    addContent(section, content) {
        const allContent = this.getAllContent();
        if (!allContent[section]) {
            allContent[section] = [];
        }
        
        // Generate unique ID
        content.id = `${section.toLowerCase()}_${Date.now()}_${Math.random().toString(36).substr(2, 9)}`;
        content.date = new Date().toISOString().split('T')[0];
        content.likes = 0;
        content.views = 0;
        content.downloads = 0;
        content.shares = 0;
        content.status = window.currentUser?.role === 'admin' ? 'approved' : 'pending';
        
        allContent[section].push(content);
        localStorage.setItem(this.storageKey, JSON.stringify(allContent));
        return content;
    }
    
    updateContent(contentId, updates) {
        const allContent = this.getAllContent();
        
        for (const section in allContent) {
            const contentIndex = allContent[section].findIndex(c => c.id === contentId);
            if (contentIndex !== -1) {
                allContent[section][contentIndex] = { ...allContent[section][contentIndex], ...updates };
                localStorage.setItem(this.storageKey, JSON.stringify(allContent));
                return allContent[section][contentIndex];
            }
        }
        return null;
    }
    
    deleteContent(contentId) {
        const allContent = this.getAllContent();
        
        for (const section in allContent) {
            const contentIndex = allContent[section].findIndex(c => c.id === contentId);
            if (contentIndex !== -1) {
                allContent[section].splice(contentIndex, 1);
                localStorage.setItem(this.storageKey, JSON.stringify(allContent));
                return true;
            }
        }
        return false;
    }
    
    likeContent(contentId) {
        const allContent = this.getAllContent();
        
        for (const section in allContent) {
            const content = allContent[section].find(c => c.id === contentId);
            if (content) {
                content.likes = (content.likes || 0) + 1;
                localStorage.setItem(this.storageKey, JSON.stringify(allContent));
                return content.likes;
            }
        }
        return 0;
    }
    
    incrementViews(contentId) {
        const allContent = JSON.parse(localStorage.getItem(this.storageKey) || '{}');
        
        for (const section in allContent) {
            const content = allContent[section].find(item => item.id === contentId);
            if (content) {
                content.views = (content.views || 0) + 1;
                localStorage.setItem(this.storageKey, JSON.stringify(allContent));
                return content.views;
            }
        }
        return 0;
    }
    
    incrementDownloads(contentId) {
        const allContent = JSON.parse(localStorage.getItem(this.storageKey) || '{}');
        
        for (const section in allContent) {
            const content = allContent[section].find(item => item.id === contentId);
            if (content) {
                content.downloads = (content.downloads || 0) + 1;
                localStorage.setItem(this.storageKey, JSON.stringify(allContent));
                return content.downloads;
            }
        }
        return 0;
    }
    
    incrementShares(contentId) {
        const allContent = JSON.parse(localStorage.getItem(this.storageKey) || '{}');
        
        for (const section in allContent) {
            const content = allContent[section].find(item => item.id === contentId);
            if (content) {
                content.shares = (content.shares || 0) + 1;
                localStorage.setItem(this.storageKey, JSON.stringify(allContent));
                return content.shares;
            }
        }
        return 0;
    }
    
    getContentById(contentId) {
        const allContent = JSON.parse(localStorage.getItem(this.storageKey) || '{}');
        
        for (const section in allContent) {
            const content = allContent[section].find(item => item.id === contentId);
            if (content) {
                return content;
            }
        }
        return null;
    }
}

// Initialize UGC Manager
const ugcManager = new UGCManager();

// UGC data storage
let ugcContent = [];
let currentEditingId = null;

// Initialize UGC system
function initializeUGC() {
    console.log('Initializing UGC system...');
    loadSampleUGCData();
}

// Load sample UGC data
function loadSampleUGCData() {
    ugcContent = [
        {
            id: 1,
            title: 'Novel Biomarker Discovery',
            content: 'Recent advances in proteomics have revealed potential new biomarkers for early cancer detection...',
            category: 'research',
            author: currentUser?.name || 'Anonymous',
            date: new Date('2025-06-15'),
            status: 'approved',
            tags: ['biomarkers', 'proteomics', 'cancer'],
            views: 245,
            likes: 18,
            files: ['biomarker_data.xlsx', 'analysis_report.pdf']
        },
        {
            id: 2,
            title: 'Machine Learning Tutorial',
            content: 'A comprehensive guide to implementing machine learning algorithms for genomic data analysis...',
            category: 'tutorial',
            author: 'Dr. Sarah Johnson',
            date: new Date('2025-06-14'),
            status: 'pending',
            tags: ['machine learning', 'genomics', 'tutorial'],
            views: 167,
            likes: 12,
            files: ['ml_tutorial.pdf', 'code_examples.zip']
        },
        {
            id: 3,
            title: 'Conference Presentation',
            content: 'Slides from the recent bioinformatics conference covering our latest research findings...',
            category: 'news',
            author: 'Dr. Michael Chen',
            date: new Date('2025-06-13'),
            status: 'rejected',
            tags: ['conference', 'presentation', 'bioinformatics'],
            views: 89,
            likes: 5,
            files: ['presentation.pptx']
        }
    ];
}

// Show user content management
function showUserContent() {
    if (!isLoggedIn) {
        showLogin();
        return;
    }
    
    const mainContent = document.querySelector('.main-content');
    if (mainContent) {
        // Create UGC management interface
        const ugcSection = createUGCSection();
        
        // Replace main content temporarily
        const originalContent = mainContent.innerHTML;
        mainContent.innerHTML = ugcSection;
        
        // Add back button
        const backButton = document.createElement('button');
        backButton.textContent = '← Back to Research';
        backButton.className = 'access-btn';
        backButton.style.marginBottom = '20px';
        backButton.onclick = () => {
            mainContent.innerHTML = originalContent;
            loadInitialContent(); // Reload original content
        };
        mainContent.insertBefore(backButton, mainContent.firstChild);
        
        // Load UGC items
        loadUserContentItems();
    }
}

// Create UGC section HTML
function createUGCSection() {
    return `
        <div class="ugc-section">
            <div class="ugc-header">
                <h2 class="ugc-title">
                    <i class="fas fa-edit"></i>
                    My Content
                </h2>
                <button class="ugc-add-btn" onclick="showUGCEditor()">
                    <i class="fas fa-plus"></i>
                    Create New
                </button>
            </div>
            
            <div class="ugc-filters" style="margin-bottom: 20px;">
                <button class="ugc-filter-btn active" onclick="filterUGCContent('all')">All</button>
                <button class="ugc-filter-btn" onclick="filterUGCContent('approved')">Approved</button>
                <button class="ugc-filter-btn" onclick="filterUGCContent('pending')">Pending</button>
                <button class="ugc-filter-btn" onclick="filterUGCContent('rejected')">Rejected</button>
            </div>
            
            <div class="ugc-content-list" id="ugc-content-list">
                <!-- UGC items will be loaded here -->
            </div>
            
            <div class="ugc-stats" style="margin-top: 30px; padding: 20px; background: var(--background-light); border-radius: 8px;">
                <h3 style="margin-bottom: 16px;">Content Statistics</h3>
                <div class="stats-grid">
                    <div class="stat-item-sidebar">
                        <span class="stat-number-sidebar" id="total-content">0</span>
                        <div class="stat-label">Total Content</div>
                    </div>
                    <div class="stat-item-sidebar">
                        <span class="stat-number-sidebar" id="total-views">0</span>
                        <div class="stat-label">Total Views</div>
                    </div>
                    <div class="stat-item-sidebar">
                        <span class="stat-number-sidebar" id="total-likes">0</span>
                        <div class="stat-label">Total Likes</div>
                    </div>
                    <div class="stat-item-sidebar">
                        <span class="stat-number-sidebar" id="approval-rate">0%</span>
                        <div class="stat-label">Approval Rate</div>
                    </div>
                </div>
            </div>
        </div>
    `;
}

// Load user content items
function loadUserContentItems() {
    const contentList = document.getElementById('ugc-content-list');
    if (!contentList) return;
    
    // Filter content by current user (or show all if admin)
    const userContent = currentUser?.role === 'admin' 
        ? ugcContent 
        : ugcContent.filter(item => item.author === currentUser?.name);
    
    if (userContent.length === 0) {
        contentList.innerHTML = `
            <div style="text-align: center; padding: 40px; color: var(--text-light);">
                <i class="fas fa-file-alt" style="font-size: 3em; margin-bottom: 16px;"></i>
                <h3>No content yet</h3>
                <p>Create your first piece of content to get started!</p>
                <button class="access-btn" onclick="showUGCEditor()" style="margin-top: 16px;">
                    <i class="fas fa-plus"></i> Create Content
                </button>
            </div>
        `;
        return;
    }
    
    contentList.innerHTML = userContent.map(item => createUGCItemHTML(item)).join('');
    updateUGCStats();
}

// Create UGC item HTML
function createUGCItemHTML(item) {
    const formattedDate = item.date.toLocaleDateString('en-US', {
        year: 'numeric',
        month: 'short',
        day: 'numeric'
    });
    
    return `
        <div class="ugc-item" data-status="${item.status}">
            <div class="ugc-status ${item.status}">${item.status}</div>
            <div class="ugc-item-header">
                <h3 class="ugc-item-title">${item.title}</h3>
            </div>
            <div class="ugc-item-meta">
                <span><i class="fas fa-user"></i> ${item.author}</span>
                <span><i class="fas fa-calendar"></i> ${formattedDate}</span>
                <span><i class="fas fa-tag"></i> ${item.category}</span>
                <span><i class="fas fa-eye"></i> ${item.views} views</span>
                <span><i class="fas fa-heart"></i> ${item.likes} likes</span>
            </div>
            <div class="ugc-item-content">
                ${item.content.substring(0, 150)}${item.content.length > 150 ? '...' : ''}
            </div>
            <div class="ugc-item-tags" style="margin-bottom: 12px;">
                ${item.tags.map(tag => `<span class="tag" style="background: rgba(231, 76, 60, 0.1); color: var(--primary-color); padding: 2px 8px; border-radius: 12px; font-size: 11px; margin-right: 4px;">${tag}</span>`).join('')}
            </div>
            ${item.files.length > 0 ? `
                <div class="ugc-item-files" style="margin-bottom: 12px;">
                    <strong>Attachments:</strong>
                    ${item.files.map(file => `<span style="margin-left: 8px; font-size: 12px;"><i class="fas fa-paperclip"></i> ${file}</span>`).join('')}
                </div>
            ` : ''}
            <div class="ugc-item-actions">
                <button class="ugc-action-btn edit" onclick="editUGCItem(${item.id})">
                    <i class="fas fa-edit"></i> Edit
                </button>
                <button class="ugc-action-btn delete" onclick="deleteUGCItem(${item.id})">
                    <i class="fas fa-trash"></i> Delete
                </button>
                ${currentUser?.role === 'admin' && item.status === 'pending' ? `
                    <button class="ugc-action-btn approve" onclick="approveUGCItem(${item.id})">
                        <i class="fas fa-check"></i> Approve
                    </button>
                    <button class="ugc-action-btn delete" onclick="rejectUGCItem(${item.id})">
                        <i class="fas fa-times"></i> Reject
                    </button>
                ` : ''}
                <button class="ugc-action-btn" style="background: #17a2b8; color: white;" onclick="viewUGCItem(${item.id})">
                    <i class="fas fa-eye"></i> View
                </button>
            </div>
        </div>
    `;
}

// Filter UGC content
function filterUGCContent(status) {
    // Update filter buttons
    document.querySelectorAll('.ugc-filter-btn').forEach(btn => btn.classList.remove('active'));
    event.target.classList.add('active');
    
    // Filter items
    const items = document.querySelectorAll('.ugc-item');
    items.forEach(item => {
        if (status === 'all' || item.dataset.status === status) {
            item.style.display = 'block';
        } else {
            item.style.display = 'none';
        }
    });
    
    showToast(`Showing ${status === 'all' ? 'all' : status} content`, 'info');
}

// Update UGC statistics
function updateUGCStats() {
    const userContent = currentUser?.role === 'admin' 
        ? ugcContent 
        : ugcContent.filter(item => item.author === currentUser?.name);
    
    const totalContent = userContent.length;
    const totalViews = userContent.reduce((sum, item) => sum + item.views, 0);
    const totalLikes = userContent.reduce((sum, item) => sum + item.likes, 0);
    const approvedContent = userContent.filter(item => item.status === 'approved').length;
    const approvalRate = totalContent > 0 ? Math.round((approvedContent / totalContent) * 100) : 0;
    
    // Update stat displays
    const totalContentEl = document.getElementById('total-content');
    const totalViewsEl = document.getElementById('total-views');
    const totalLikesEl = document.getElementById('total-likes');
    const approvalRateEl = document.getElementById('approval-rate');
    
    if (totalContentEl) totalContentEl.textContent = totalContent;
    if (totalViewsEl) totalViewsEl.textContent = totalViews.toLocaleString();
    if (totalLikesEl) totalLikesEl.textContent = totalLikes;
    if (approvalRateEl) approvalRateEl.textContent = `${approvalRate}%`;
}

// Edit UGC item
function editUGCItem(id) {
    const item = ugcContent.find(content => content.id === id);
    if (item) {
        currentEditingId = id;
        showUGCEditor(item);
    }
}

// Delete UGC item
function deleteUGCItem(id) {
    if (confirm('Are you sure you want to delete this content?')) {
        ugcContent = ugcContent.filter(item => item.id !== id);
        loadUserContentItems();
        showToast('Content deleted successfully', 'success');
    }
}

// Approve UGC item (admin only)
function approveUGCItem(id) {
    const item = ugcContent.find(content => content.id === id);
    if (item) {
        item.status = 'approved';
        loadUserContentItems();
        showToast('Content approved', 'success');
    }
}

// Reject UGC item (admin only)
function rejectUGCItem(id) {
    const item = ugcContent.find(content => content.id === id);
    if (item) {
        item.status = 'rejected';
        loadUserContentItems();
        showToast('Content rejected', 'error');
    }
}

// View UGC item
function viewUGCItem(id) {
    const item = ugcContent.find(content => content.id === id);
    if (item) {
        // Increment view count
        item.views++;
        
        // Create detailed view modal
        showUGCDetailModal(item);
        
        // Update display
        loadUserContentItems();
    }
}

// Show UGC detail modal
function showUGCDetailModal(item) {
    const modal = document.createElement('div');
    modal.className = 'login-modal';
    modal.style.display = 'flex';
    modal.innerHTML = `
        <div class="login-content" style="max-width: 800px;">
            <button class="close-btn" onclick="this.closest('.login-modal').remove()">&times;</button>
            <div style="margin-bottom: 20px;">
                <h2>${item.title}</h2>
                <div style="color: var(--text-light); margin-bottom: 16px;">
                    <span><i class="fas fa-user"></i> ${item.author}</span> •
                    <span><i class="fas fa-calendar"></i> ${item.date.toLocaleDateString()}</span> •
                    <span><i class="fas fa-tag"></i> ${item.category}</span>
                </div>
                <div style="margin-bottom: 16px;">
                    ${item.tags.map(tag => `<span style="background: rgba(231, 76, 60, 0.1); color: var(--primary-color); padding: 4px 8px; border-radius: 12px; font-size: 12px; margin-right: 8px;">${tag}</span>`).join('')}
                </div>
            </div>
            <div style="background: var(--background-light); padding: 20px; border-radius: 8px; margin-bottom: 20px;">
                <p style="line-height: 1.6; color: #444;">${item.content}</p>
            </div>
            ${item.files.length > 0 ? `
                <div style="margin-bottom: 20px;">
                    <h4>Attachments</h4>
                    <div style="margin-top: 10px;">
                        ${item.files.map(file => `
                            <div style="display: flex; align-items: center; padding: 8px; background: white; border: 1px solid var(--border-light); border-radius: 4px; margin-bottom: 8px;">
                                <i class="fas fa-file" style="margin-right: 8px; color: var(--primary-color);"></i>
                                <span>${file}</span>
                                <button style="margin-left: auto; background: var(--primary-color); color: white; border: none; padding: 4px 8px; border-radius: 4px; font-size: 12px; cursor: pointer;">Download</button>
                            </div>
                        `).join('')}
                    </div>
                </div>
            ` : ''}
            <div style="display: flex; justify-content: space-between; align-items: center; padding-top: 16px; border-top: 1px solid var(--border-light);">
                <div style="color: var(--text-light); font-size: 14px;">
                    <span><i class="fas fa-eye"></i> ${item.views} views</span> •
                    <span><i class="fas fa-heart"></i> ${item.likes} likes</span>
                </div>
                <button onclick="likeUGCItem(${item.id}); this.innerHTML='<i class=\\"fas fa-heart\\"></i> Liked'" 
                        style="background: var(--primary-color); color: white; border: none; padding: 8px 16px; border-radius: 4px; cursor: pointer;">
                    <i class="fas fa-heart"></i> Like
                </button>
            </div>
        </div>
    `;
    
    document.body.appendChild(modal);
    document.body.style.overflow = 'hidden';
    
    // Remove modal when clicking outside
    modal.addEventListener('click', (e) => {
        if (e.target === modal) {
            modal.remove();
            document.body.style.overflow = '';
        }
    });
}

// Like UGC item
function likeUGCItem(id) {
    const item = ugcContent.find(content => content.id === id);
    if (item) {
        item.likes++;
        updateUGCStats();
        showToast('Content liked!', 'success');
    }
}

// Helper function to generate excerpt from content
function generateExcerpt(content, maxLength = 150) {
    if (!content) return '';
    
    // Remove markdown formatting for excerpt
    let excerpt = content
        .replace(/#{1,6}\s+/g, '') // Remove headers
        .replace(/\*\*(.*?)\*\*/g, '$1') // Remove bold
        .replace(/\*(.*?)\*/g, '$1') // Remove italic
        .replace(/```[\s\S]*?```/g, '[Code block]') // Replace code blocks
        .replace(/`(.*?)`/g, '$1') // Remove inline code
        .replace(/\[([^\]]+)\]\([^)]+\)/g, '$1') // Remove links, keep text
        .replace(/\n+/g, ' ') // Replace newlines with spaces
        .trim();
    
    if (excerpt.length > maxLength) {
        excerpt = excerpt.substring(0, maxLength).trim() + '...';
    }
    
    return excerpt;
}

// Add filter button styles
const filterButtonStyles = `
.ugc-filter-btn {
    background: transparent;
    border: 1px solid var(--border-light);
    padding: 8px 16px;
    border-radius: 4px;
    margin-right: 8px;
    cursor: pointer;
    transition: var(--transition);
    font-size: 14px;
    color: var(--text-light);
}

.ugc-filter-btn.active,
.ugc-filter-btn:hover {
    background: var(--primary-color);
    color: white;
    border-color: var(--primary-color);
}

.tag {
    display: inline-block;
}
`;

// Inject filter styles
if (!document.querySelector('#ugc-filter-styles')) {
    const style = document.createElement('style');
    style.id = 'ugc-filter-styles';
    style.textContent = filterButtonStyles;
    document.head.appendChild(style);
}

// Initialize UGC when DOM is loaded
document.addEventListener('DOMContentLoaded', initializeUGC);

// Make UGC Manager globally available
window.ugcManager = ugcManager;

// Export additional utility functions
window.generateExcerpt = generateExcerpt;

// Export UGC functions
window.showUserContent = showUserContent;
window.filterUGCContent = filterUGCContent;
window.editUGCItem = editUGCItem;
window.deleteUGCItem = deleteUGCItem;
window.approveUGCItem = approveUGCItem;
window.rejectUGCItem = rejectUGCItem;
window.viewUGCItem = viewUGCItem;
window.likeUGCItem = likeUGCItem;
